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4ABSTRACT
Globus is a non-painful sensation of a lump in the throat, which frequently improves with eating. 
Globus is a common symptom; however, little is known about the etiology, and the causes have 
remained controversial. Dysphagia, diffi  culty of swallowing, is also a common symptom aff ecting 
patients referred to otorhinolaryngological practice. Although globus patients lack swallowing 
diffi  culties, globus and dysphagia symptoms are oft en mixed together and are hard for patients 
and even clinicians to distinguish. Identifying the stage of the swallowing process at which the 
problem occurs directs us to possible further investigations in dysphagia diagnostics. Th e aim of 
this thesis was to investigate the etiology of globus, to clarify globus and dysphagia diagnostics, 
and to describe the natural course of these symptoms.
In the fi rst study of this thesis, we examined the esophageal background of globus with 
transnasal esophagoscopy, high-resolution manometry, and 24-hour multichannel intraluminal 
impedance and pH monitoring. We had 30 globus patients and, as controls, 24 patients who were 
referred to the Department of Abdominal Surgery for evaluation of operative treatment because 
of diffi  cult refl ux symptoms. Th e study indicated that globus patients without refl ux symptoms 
did not have acid or non-acid gastroesophageal refl ux disease (GERD), the upper esophageal 
sphincter (UES) pressure was not elevated, and esophageal motor disorders diagnosed were 
mainly minor, a fi nding evident in healthy subjects, as well. However, globus patients had 
supragastric belching more oft en than controls with refl ux, leading to a question of its possible 
role in some of the globus patients’ symptoms.
In the second study, we examined how these 30 globus patients’ symptoms evolved over a 
four-month follow-up measured by the Refl ux Symptom Index (RSI), the Deglutition Handicap 
Index (DHI), and 15-Dimensional Measure of Health-Related Quality of Life (15-D). By 
analyzing patients’ videolaryngoscopies using the Refl ux Finding Score (RFS), we determined 
whether patients had fi ndings of laryngopharyngeal refl ux (LPR). A speech and language 
pathologist (SLP) interviewed and examined globus patients aft er four months to investigate 
if patients with persistent symptoms had problems with their voices. We observed that globus 
patients felt symptom relief in the RSI and DHI aft er a four-month follow-up without any 
treatment. None of the videolaryngoscopies revealed an LPR. Th e SLP found six patients with 
simultaneous functional voice problems, possibly associated with persistent globus.
In the third and fourth study, we searched from the hospital database all globus (n=76) 
and dysphagia (n=303) patients, respectively, who were referred to our clinic in 2009. From the 
medical records, we surveyed patients’ symptoms, investigations, fi ndings, and treatment. From 
the Finnish Cancer Registry (FCR) database, we recorded all of these patients’ cancer diagnoses 
at the end of 2012. In the third study, the questionnaire concerning the globus patients’ present 
symptoms was sent three and six years aft er their initial visit. Based on both questionnaires, 
half of the globus patients were asymptomatic or had fewer symptoms, whereas the rest suff ered 
persistent symptoms. Videofl uorography and neck ultrasound showed no benefi t in globus 
diagnostics. Th e FCR data revealed no malignancies associated with globus during the follow-up 
to the end of 2012. 
In the fourth study, dysphagia patients received a questionnaire about their current 
symptoms three years aft er their visit to our clinic. Th e questionnaires showed that almost half of 
the dysphagia patients were asymptomatic or had milder symptoms, implying that spontaneous 
recovery may occur. Based on the case records, most dysphagia diagnoses remained unspecifi c 
5dysphagia (55%) despite performing many investigations. All patients with a malignant disease 
either already had a positive fi nding at the ear, nose, and throat examination or suff ered from 
alarming signs, such as progressive dysphagia symptoms, leading to gastroscopy, which revealed 
the diagnosis. Th e FCR data indicated no additional malignant cases during the three-year 
follow-up. 
Our study clarifi es the esophageal background of globus, but also off ers some new insights 
into possible causes. Th e study updates globus and dysphagia diagnostics and presents the 
natural course of these symptoms. According to our study, many swallowing diffi  culties are mild 
and no specifi c cause can be identifi ed. Our results emphasize the importance of a careful clinical 
evaluation to fi nd possible malignancies and to determine whether further investigations in 
dysphagia diagnostics are necessary. 
6TIIVISTELMÄ
Globuksella eli palantunteella tarkoitetaan kivutonta kurkussa tuntuvaa oiretta, joka yleensä 
helpottaa syödessä. Vaikka palantunne on yleinen vaiva, tiedetään sen aiheuttajista vain 
vähän. Dysfagia eli nielemisvaikeus on toinen yleinen oire korva-, nenä- ja kurkkutautien 
(KNK) poliklinikalla. Vaikka palantunnepotilailla ei määritelmällisesti ole nielemiseen liittyviä 
vaikeuksia, palantunne- ja nielemisvaikeusoireet menevät usein sekaisin, ja sekä potilaan että 
lääkärin saattaa olla hankala erottaa vaivoja toisistaan. Nielemisvaikeudesta kärsivää potilasta 
tutkittaessa on tärkeää selvittää, mihin nielemisen vaiheeseen ongelma liittyy, jotta mahdolliset 
tarvittavat jatkotutkimukset voidaan määrätä. Väitöskirjan tavoitteena oli tutkia palantunteen 
syitä, selventää palantunteen ja nielemisvaikeuden diagnostiikkaa sekä kuvata näiden oireiden 
luonnollista kulkua.
Väitöskirjan ensimmäisessä osatyössä tutkittiin palantunteen ruokatorviperäisiä syitä 
nenän kautta tehtävällä ruokatorven ja mahalaukun tähystyksellä (transnasal esophagoscopy, 
TNE), tarkkuusmanometrialla (high-resolution manometry, HRM) sekä impedanssin ja pH:n 
pitkäaikaisrekisteröinnillä (24-hour multichannel intraluminal impedance and pH monitoring, 
24-h MII-pH). Tutkimuksessa oli 30 HYKS:n Korvaklinikkaan lähetettyä palantunnepotilasta, 
ja kontrolliryhmänä toimi 24 hankalasta refl uksista kärsivää potilasta, jotka oli lähetetty tämän 
vuoksi HYKS:n vatsaelinkirurgian klinikkaan leikkausarvioon. Tutkimuksessa todettiin, että 
niillä palantunnepotilailla, jotka eivät kärsineet närästysoireesta, ei ollut hapanta tai ei-hapanta 
refl uksitautia, ruokatorven yläsulkijan paine ei ollut koholla ja diagnosoidut ruokatorven 
liikehäiriöt olivat pääosin lieviä, joiden kaltaisia voidaan löytää myös terveillä henkilöillä. 
Kuitenkin palantunnepotilailla oli ruokatorviröyhtäilyä yleisemmin kuin refl uksista kärsivillä 
kontrollipotilailla, mikä herättää kysymyksen sen mahdollisesta yhteydestä palantunteeseen.
Toisessa osatyössä selvitettiin refl uksin oirekyselyä (Refl ux Symptom Index, RSI), 
nielemisen oirekyselyä (Deglutition Handicap Index, DHI) sekä 15-D elämänlaatukyselyä 
(15-D) käyttäen, kuinka näiden 30 palantunnepotilaan oireet muuttuivat neljän kuukauden 
seurannassa. Selvittääksemme potilaiden mahdollisia kurkunpään refl uksiin viittaavia löydöksiä 
arvioimme potilaiden videolaryngoskopiat refl uksin löydöspisteytyksellä (Refl ux Finding 
Score, RFS). Puheterapeutti haastatteli ja tutki palantunnepotilaat neljän kuukauden kuluttua 
ensikäynnistä selvittääksemme, oliko edelleen oireilevilla palantunnepotilailla ääneen liittyviä 
ongelmia. RSI:lla ja DHI:lla mitattuna palantunnepotilaiden oireet lievittyivät neljän kuukauden 
seurannassa ilman hoitoa. Kenenkään potilaan videolaryngoskopian löydös ei viitannut 
kurkunpään refl uksiin. Puheterapeutti löysi kuudelta potilaalta ääneen liittyviä ongelmia, jotka 
voivat olla myötävaikuttava tekijä palantunteen jatkumiselle.
Kolmannessa ja neljännessä osatyössä haimme sairaalan tietokannasta kaikki 76 
palantunne- ja 303 nielemisvaikeuspotilasta, jotka oli lähetetty HYKS:n Korvaklinikkaan 
vuonna 2009. Keräsimme tiedot potilaiden oireista, tutkimuksista, löydöksistä ja hoidosta. 
Kaikkien potilaiden vuoteen 2012 mennessä saamat syöpädiagnoosit pyydettiin Suomen 
Syöpärekisteristä. Kolmannessa osatyössä palantunnepotilaille lähetettiin kysely heidän 
senhetkisistä oireistaan kolmen ja kuuden vuoden kuluttua ensikäynnistä. Kummankin kyselyn 
perusteella puolet palantunnepotilaista olivat oireettomia tai heidän oireensa olivat lievittyneet, 
kun taas loput potilaista kärsivät edelleen palantunteesta. Videofl uorografi a ja kaulan ultraääni 
eivät olleet hyödyllisiä palantunnepotilaiden diagnostiikassa. Syöpärekisterin tiedot vahvistivat, 
ettei kenenkään palantunnepotilaan oire ollut kehittynyt syöväksi kolmen vuoden seurannassa.
7Neljännessä osatyössä nielemisvaikeuspotilaille lähetettiin oirekysely kolme 
vuotta ensikäynnin jälkeen. Palautettujen oirekyselyiden mukaan puolet vastanneista 
nielemisvaikeuspotilaista olivat oireettomia tai heidän oireensa olivat lievittyneet, mikä osoittaa, 
että nielemisvaikeuksilla on myös spontaani toipumismahdollisuus. Potilastietojen perusteella yli 
puolessa tapauksista nielemisvaikeuspotilaan diagnoosi jäi epäselväksi, vaikka potilaita tutkittiin 
melko paljon. Kaikilla potilailla, joilla nielemisvaikeuden syy oli syöpä, löydös oli ollut nähtävissä 
jo KNK-tutkimuksessa tai potilaalla oli ollut hälyttäviä oireita, kuten etenevää nielemisvaikeutta, 
jonka vuoksi tehty gastroskopia paljasti syöpädiagnoosin. Syöpärekisterin tiedot vahvistivat, ettei 
kenellekään muulle nielemisvaikeudesta kärsivälle potilaalle kehittynyt tähän oireeseen liittyvää 
syöpää kolmen vuoden seurannassa. 
Tutkimuksemme selventää palantunteen ruokatorviperäistä taustaa mutta löytää myös uusia 
mahdollisia syitä oireelle. Tutkimus päivittää palantunteen ja nielemisvaikeuden diagnostiikkaa 
ja esittelee näiden oireiden luonnollista kulkua. Monet nielemisvaikeudet ovat lieviä, eikä oireelle 
löydy erityistä syytä. Tuloksemme painottavat kliinisen arvion tärkeyttä mahdollisen syövän 
löytämiseksi oireen taustalta ja arvioitaessa, tarvitseeko nielemisvaikeuspotilas jatkotutkimuksia. 
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 1 INTRODUCTION
Globus (Latin globus = globe), the feeling of a lump in the throat, is a general symptom especially 
aff ecting women under 50 years. Among apparently healthy adults in a community, globus can 
aff ect up to 46% (Th ompson & Heaton 1982). Th e etiology of globus is disputable, leading to 
disagreement regarding how these patients should be examined and treated. Historically, globus 
was considered a psychological problem (Merskey & Merskey 1993). Currently, it is obvious that 
the causes are rather multiform, although some patients’ symptoms may have a psychological 
background. Gastroesophageal refl ux disease (GERD), laryngopharyngeal refl ux (LPR), 
esophageal motor disorders, and improper upper esophageal sphincter (UES) function are 
suggested to cause globus (Koufman 1991, Corso et al. 1998, Gooi et al. 2014). However, studies 
demonstrating the causal relationship between these disorders and globus are inadequate.
Currently, methods suitable for investigation of the esophageal etiology of globus 
are available. High-resolution manometry (HRM) provides more accurate diagnostics on 
UES pressure and in esophageal motor disorders  (Peng et al. 2015). Combined esophageal 
multichannel intraluminal impedance and pH monitoring (MII-pH) distinguishes acid and 
non-acid refl ux, as well as allows detection of possible proximal refl ux, and has the ability to 
defi ne whether refl uxiates are liquid, gas, or mixed (Zerbib et al. 2006). Moreover, a transnasal 
esophagoscopy (TNE) enables a well-tolerated endoscopy to be performed under local anesthesia 
(Postma 2006). However, only a limited number of studies have used some of these methods in 
globus diagnostics.
Common treatment for globus has been to explain the benign nature of the symptom to the 
patient (Galmiche et al. 2006). An outpatient examination has been suggested to be suffi  cient 
in patients with typical globus (Harar et al. 2004). However, many globus patients undergo 
further diagnostics such as radiographic swallowing examinations. It has been proposed that 
attention and reassurance alleviates globus symptoms, but contrary results also exist (Khalil et 
al. 2003, Millichap et al. 2005). Accordingly, some investigations may be performed to exclude 
a malignancy and to ensure both the patient and the clinician that the symptoms are harmless. 
Dysphagia is a general symptom particularly aff ecting the elderly. Nearly 23% of patients in 
primary care experience swallowing diffi  culties (Wilkins et al. 2007). Patients with oropharyngeal 
dysphagia may have diffi  culties in starting to swallow, they may aspirate their food, or food may 
regurgitate into the nasopharynx. In esophageal dysphagia, a typical sign is food impaction in 
the esophagus. Many patients have a mild symptom, never talking to their physician (Wilkins et 
al. 2007). Since dysphagia is a common symptom, there is a need for a standardized diagnostic 
protocol to target possible further investigations properly. Despite investigations, some dysphagia 
patients never get a diagnosis (Hoy et al. 2013). Whether these symptoms may alleviate or 
progress into a malignancy in the long term is not known. 
Th e aim of this study was to investigate the possible esophageal background of globus, to 
update globus and dysphagia diagnostics, and to evaluate the natural course of these symptoms.
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2 REVIEW OF THE LITERATURE
2.1 GLOBUS
2.1.1 DEFINITION AND PREVALENCE 
Globus was already recognized in the time of Hippocrates. Historically, it was considered to be a 
hysterical symptom (Greek hystericus = related to uterus), globus hystericus, especially aff ecting 
anxious women (Merskey & Merskey 1993). In 1968, Malcomson observed that not all globus 
patients were hysterical or female and suggested use of the term globus pharyngeus (Malcomson 
1968). 
Overall, globus seems to be equally prevalent in healthy women and men (Batch 1988a). 
However, the symptom aff ects women age 50 and below three times more than men, and women 
are also more likely to seek medical advice regarding the symptom (Moloy & Charter 1982, 
Batch 1988a). Globus represents about 4% of new referrals to ear, nose, and throat (ENT) clinics 
(Deary et al. 1995). However, up to 78% of patients at other clinics have been found to suff er 
from globus-like symptoms, but had never sought health care for those symptoms (Ali & Wilson 
2007).
2.1.2 ETIOLOGY
2.1.2.1 Gastroesophageal refl ux disease
Gastroesophageal refl ux disease (GERD) is defi ned as a condition in which the refl ux of gastric 
contents causes diffi  cult symptoms and/or complications (Vakil et al. 2006). Th e causative role 
of GERD in globus is disputable. Malcomsom (1968) was the fi rst to connect globus and GERD 
using barium swallow to show refl ux in over 60% of globus patients. Th ereaft er, Cherry et al. 
(1970) demonstrated that 10 patients out of 12 reported globus aft er acid was supplied to the 
distal esophagus. Moreover, GERD was suggested to be a major cause of the symptom in up 
to 58% of globus patients with abnormal pH results (Koufman 1991). However, based on an 
ambulatory pH study, in a retrospective setting, fi ndings of GERD were not more common in 
patients with globus than in controls  (Corso et al. 1998).
In the past decade, the association of globus symptoms with GERD has been clarifi ed. 
Globus is now considered to be a manifestation of a functional esophageal disorder, and when a 
patient has a globus symptom directly related to refl ux the patient is considered to have GERD, 
even if other objective GERD fi ndings are lacking (Galmiche et al. 2006). However, with use of 
new advanced investigation methods, it is expected that knowledge of the causative role of GERD 
as an etiological factor for globus will increase. Currently, large, prospective, and controlled 
studies are lacking.
2.1.2.2 Laryngopharyngeal refl ux
Laryngopharyngeal refl ux (LPR) is considered to be an extraesophageal indication of refl ux 
disease. In LPR, the retrograde fl ow of gastric contents comes in contact with the mucosa of 
the upper aerodigestive tract (Ford 2005). In contrast to esophageal mucosa, the larynx and 
pharynx are very sensitive to gastric refl ux, so patients with LPR a more likely to have laryngeal 
symptoms, such as throat cleaning, but do not necessarily have symptoms of GERD, which 
requires frequent and prolonged exposure to refl ux (Koufman 1991, Koufman et al. 1996, Phua 
Review of the Literature
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et al. 2005). Although hoarseness, cough, and throat cleaning are usually considered to be LPR 
symptoms, these symptoms are unspecifi c and may be caused by other disorders as well (Tauber 
et al. 2002). A study by Gooi et al. (2014) found that up to 48% of otolaryngologists considered 
LPR to be highly related to globus. However, the possible connection of globus and LPR has not 
been clarifi ed. 
Th e laryngeal fi ndings indicating LPR are also unspecifi c and prone to under- and 
overestimation (Kelchner et al. 2007, Musser et al. 2011). Moreover, the prevalence of these 
mucosal fi ndings suggesting refl ux is reported as high as 70% in normal volunteers (Hicks et al. 
2002). Th erefore, the diagnostic criteria for LPR have not met with universal consensus (Gooi et 
al. 2014). 
2.1.2.3 Abnormal upper esophageal sphincter func? on
Several decades ago, Watson and Sullivan (1974) investigated globus patients and controls with 
manometry and found that cricopharyngeal sphincter pressure was statistically signifi cantly 
higher in patients with globus. However, Cook et al. (1989) found in their study of 7 globus 
patients and 13 healthy controls that globus patients’ resting upper esophageal sphincter (UES) 
pressure and its response to stress were normal. Moreover, in a study of 32 globus patients and 24 
healthy volunteers, no statistical diff erence was found in UES resting pressure (Sun et al. 2002). 
Nonetheless, a strong association between hypertonicity of the UES and globus in conventional 
manometry was found in one retrospective study (Corso et al. 1998).
Currently, high-resolution manometry (HRM) is a more precise diagnostic method in the 
evaluation of the esophageal sphincter pressure  (Peng et al. 2015). Kwiatek et al. (2009) used 
HRM to quantify the timing and magnitude of respiratory variation of the UES and discovered 
that in globus patients, respiration-related change in the resting UES pressure was signifi cantly 
amplifi ed compared to controls and GERD patients. In one retrospective study, UES basal and 
residual pressures between globus and dysphagia patients, as well as normal controls, were 
evaluated. Th e study showed that mean UES basal and residual pressures were normal in both 
globus patients and normal controls (Peng et al. 2015). Moreover, a study by Choi et al. (2013) 
showed that globus patients did not have elevated UES pressure upon HRM, compared to normal 
controls and patients with GERD. 
2.1.2.4 Esophageal motor disorders
Only a limited number of studies have evaluated esophageal motor disorders as a possible 
cause or contributing factor in globus. Wilson et al. (1989) demonstrated that there were no 
diff erences between globus patients’ and controls’ esophageal body motility upon manometry. In 
another study, 67% of globus patients’ esophageal manometry was abnormal, however, the most 
frequent fi nding (29%) was a nonspecifi c esophageal motility disorder  (Färkkilä et al. 1994). In 
their prospective study, Knight et al. (2000) evaluated patients with suspected extraesophageal 
manifestations of GERD, such as globus. Upon esophageal manometry, 7 globus patients 
out of 12 had nonspecifi c esophageal disorders, while 2 had a hypertensive lower esophageal 
sphincter (LES) and 3 had normal results (Knight et al. 2000). Consequently, the esophageal 
motor disorders most oft en diagnosed in globus patients have been nonspecifi c. Nevertheless, 
it is expected that the use of a more accurate method, like HRM, may clarify the possible role of 
esophageal motor disorders in globus.
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2.1.2.5 Psychological factors and stress
Historically, the term globus hystericus was used to suggest a psychological origin to the 
symptom, and in fact, many studies have shown this. In a study by Deary et al. (1992), globus 
patients were signifi cantly more depressed than controls. Globus patients had also more stress 
and severe life events throughout the year compared to controls in another study (Harris et al. 
1996). Middle-aged women with globus were signifi cantly more likely to experience neuroticism, 
to be less extroverted, and to have psychological distress, such as anxiety, low mood, and somatic 
concerns (Deary et al. 1995). Furthermore, up to 96% of globus patients felt more symptoms 
when a highly emotional state occurred (Th ompson & Heaton 1982). 
However, in one Finnish study, globus patients and the general population had a similar 
prevalence of psychiatric disorders (Färkkilä et al. 1994). Additionally, in a study by Moser et al. 
(1991) mean scores were similar for anxiety, depression, hysteria, and hypochondria in globus 
patients compared to general medical outpatients. Although the symptom’s complex causes are 
accepted, it is still labelled as code F45.8, meaning somatoformic disorder, in the international 
classifi cation of diseases, 10th edition, (ICD-10) (Word Health Organization 2016).
2.1.2.6 Other causes
Conditions causing irritation or infl ammation in the pharynx and larynx, such as pharyngitis 
and postnasal drip, may increase local sensitivity and cause globus (Batch 1988b). Anatomical 
causes, including tongue base hypertrophy and a retroverted epiglottis touching the posterior 
pharyngeal wall, have been considered as local factors inducing globus (Mamede et al. 2004, 
Agada et al. 2007).
Some studies have investigated thyroid pathology and globus. One-third of patients with 
thyroidal mass experienced globus-like symptoms before thyroid surgery (Burns & Timon 
2007). In one prospective study, thyroid nodules larger than 3 cm located anterior to the trachea 
were associated with globus (Nam et al. 2015). However, thyroidal fi ndings, such as nodules, are 
common coincidence fi ndings in healthy subjects, so their causative role in globus requires more 
investigation. 
To exclude malignancy, many patients undergo further investigations. One retrospective 
study of 699 patients showed that typical globus symptoms were not hiding malignancy behind 
the symptom at the initial visit, whereas 5 patients with atypical symptoms revealed malignancies 
(Harar et al. 2004). 
2.1.3 EXAMINATIONS USED IN GLOBUS DIAGNOSTICS
Because the etiology of globus is unclear, uniform investigation strategy is lacking. Taking a 
careful clinical history is essential in order to determine whether a patient should be referred 
for further investigation, such as a radiological examination or direct esophagoscopy (Ardran 
1982). However, globus patients without other symptoms are mainly diagnosed based on their 
history and a clinical examination, including neck palpation and nasolaryngoscopic examination 
(Galmiche et al. 2006). Pathological fi ndings in globus patients can be detected by a clinical 
examination with fi ber-optic nasoendoscope (Harar et al. 2004). Further investigations are not 
recommended when a patient has typical globus (Galmiche et al. 2006). 
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2.1.3.1 Neck ultrasound
Neck ultrasound is occasionally used in globus diagnostics. However, studies evaluating its 
usefulness are lacking. Th ere are a few studies, which have assessed neck ultrasound fi ndings in 
globus patients, but they have investigated only thyroid pathology (Burns & Timon 2007, Nam 
et al. 2015). 
2.1.3.2 Videofl uorography
Videofl uorography is quite oft en used in globus diagnostics, although its benefi t has not been 
proven (Webb et al. 2000). Ardran (1982) examined 300 globus patients with a cineradiographic 
examination: patients swallowed a fl uid barium suspension showing that there was no visible 
lump in the throat. Also, a modifi ed barium swallow study with esophagogram showed no benefi t 
in globus diagnostics (Dworkin et al. 2015). Moreover, Luk et al. (2014) reviewed barium swallow 
pharyngoesophagographies of 908 globus patients and 86% had totally normal results. Authors 
concluded that the examination has limited diagnostic value and is therefore not recommended 
for globus patients; patients under 30 years old, in particular, had no fi ndings.
2.1.3.3 Endoscopy
Rigid endoscopy has been the gold standard in otorhinolaryngologic practice when an 
endoscopic examination is needed. However, because it is an invasive investigation, it requires 
general anesthesia and the risk for esophagus perforation during the diagnostic endoscopic 
procedure has been reported to be up to 1.2% (Kubba et al. 2003). Rigid endoscopy has not been 
shown to be useful in globus diagnostics. Nonetheless, a survey concerning ENT consultants 
indicated that 61% of respondents used rigid endoscope in globus diagnostics (Webb et al. 
2000). A retrospective study of 250 globus patients examined with rigid endoscopy showed no 
malignancies and the status of the larynx, pharynx, and upper esophagus was entirely normal in 
87% (Takwoingi et al. 2006). 
Transnasal esophagoscopy (TNE) allows examining the upper aerodigestive tract with a thin 
endoscope without sedation. Shaker, a gastroenterologist, published the initial report of TNE in 
1994 (Shaker 1994). However, Aviv et al. (2001) were the fi rst to publish a study of unsedated 
TNE in a laryngological practice. Th e procedure is performed on a sitting patient and, aft er a 
local anesthetic is applied to the nasal cavity, the thin endoscope is passed transnasally (Postma 
et al. 2005). TNE enables examination of the nasopharynx, hypopharynx, and larynx before the 
endoscope is passed into the esophagus, and a working channel provides an opportunity for 
taking biopsies (Postma et al. 2005). 
TNE has been found to be safe and patients tolerate it well (Dean et al. 1996, Postma 
et al. 2005, Th ota et al. 2005, Streckfuss et al. 2014). Patients prefer TNE to conventional 
esophagogastroduodenoscopy (EGD), and TNE is potentially more cost-eff ective (Dean et al. 
1996, Th ota et al. 2005). Globus is considered to be one of the indications for TNE (Postma et al. 
2005, Amin et al. 2008).
2.1.3.4 Manometry
Th e possible connection between globus and esophageal motor disorders or elevated UES 
pressure has not been clarifi ed. Previously, a conventional manometry with fi ve to eight pressure 
sensors was a standard investigation method used upon suspicion of an esophageal bolus 
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transit pathology (Fox et al. 2004). However, patients’ symptoms and manometric fi ndings are 
considered to be poorly associated (Kahrilas et al. 1994). 
Currently, HRM gives more precise information about an abnormal bolus transport, 
esophageal motility disorders, and UES pressure (Fox et al. 2004, Peng et al. 2015), and it has 
recently been studied in globus diagnostics  (Kwiatek et al. 2009, Choi et al. 2013, Peng et al. 
2015).
2.1.3.5 pH monitoring and 24-hour mul? channel intraluminal impedance 
Previously, esophageal pH monitoring was a gold standard for investigating esophageal refl ux 
events in GERD diagnostics (Zerbib et al. 2006). However, it was not able to detect weakly acidic 
or non-acidic refl ux. Multichannel intraluminal impedance (MII) detects all refl ux events: liquid, 
gas, or mixed  (Sifrim et al. 1999, Zerbib et al. 2006). Moreover, when MII is combined with 
pH monitoring, it allows for detection of acid and non-acid refl ux episodes and for analyzing 
associations between a patient’s symptoms and MII-pH fi ndings (Vela et al. 2001, Zerbib et al. 
2006).  
2.1.4 TREATMENT
Because the etiology of globus is unclear, there is no strategy regarding how to treat globus 
patients. Proton pump inhibitor (PPI) medication is oft en prescribed because it has been 
suggested that globus may be related to GERD and LPR. Because exact GERD diagnostics 
require invasive and expensive examinations, empirical PPI therapy to diagnose and treat 
possible refl ux is common. GERD responds well to PPI medication, but LPR’s response to this 
medication varies and may require higher doses and longer treatment periods (Katz & Castell 
2000, Park et al. 2005). One prospective, uncontrolled study demonstrated no changes in gene 
expression of cytokines related to infl ammation when biopsies were taken from the posterior 
larynx tissue before and aft er a 10-week therapy of PPI (Th ibeault et al. 2007). In addition, a 
meta-analysis concluded that using high-dose PPIs are no more eff ective than placebo in the 
treatment of laryngo-pharyngeal symptoms possibly connected to GERD (Gatta et al. 2007). 
Moreover, placebo has been as eff ective as PPIs in resolving globus symptoms (Noordzij et al. 
2001, Vaezi et al. 2006).
When concomitant with disorders such a major depression or panic disorder, anti-
depressants have been benefi cial in resolving the globus symptoms as well, though study sample 
sizes were small (Brown et al. 1986, Cybulska 1997).
Globus patients with a thyroidal mass experienced improvement aft er thyroid surgery 
(Burns & Timon 2007). Moreover, globus patients with an epiglottis touching the posterior wall 
of the pharynx became asymptomatic aft er partial epiglottectomy (Agada et al. 2007). However, 
both of these studies lacked controls. Consequently, it is impossible to determine the operations’ 
possible placebo eff ect. 
Reducing laryngopharyngeal tension with neck and shoulder exercises, and relaxation 
techniques with voice hygiene and voice exercises improved 92% of globus patients’ symptoms 
in one uncontrolled study (Wareing et al. 1997). In a sample of 36 globus patients, a speech 
and language pathologist (SLP) treated half of the globus patients with exercises to relieve 
laryngopharyngeal tension while controls were only given reassurance by a nurse. Aft er three 
months, patients in the SLP group had signifi cant improvement in their symptoms compared 
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to the control group (Khalil et al. 2003). However, whether globus patients only benefi t from 
attention, rather than the SLP’s therapy, remains ambiguous.
2.1.5 PROGNOSIS
In globus patients, rapid symptom relief is oft en unlikely. During a follow-up period of an 
average of 7.6 years, 55% became asymptomatic and 45% had persistent symptoms (Rowley et 
al. 1995). In a study with a shorter follow-up, an average of 27 months, 50% of patients became 
asymptomatic or experienced symptom relief (Timon et al. 1991). Male gender, short duration 
of the globus symptom, and no other throat symptoms were associated with rapid resolution of 
symptoms (Timon et al. 1991).
2.2 DYSPHAGIA
2.2.1 DEFINITION AND PREVALENCE
Dysphagia aff ects the elderly in particular because the neurophysiology of normal swallowing 
alters with age (Jaradeh 1994). In a community, 5% to 8% of individuals over 50 report dysphagia 
(Lindgren & Janzon 1991). Th e prevalence increases to 16%, if considering patients over 80 
(Bloem et al. 1990). Many age-related changes may contribute to an impaired pharyngeal 
swallow, such as diminished cooperation between the oral and pharyngeal phase of swallowing, 
and delayed anterior movement of the hyoid bone (Plant 1998). Problems in swallowing have a 
potential eff ect on nutrition, as well as a patient’s quality of life.
2.2.2 PHYSIOLOGY OF DEGLUTITION
Swallowing is a complex process. Th e brainstem receives input from the cerebral cortex and 
coordinates the motor and sensory activity of the swallowing process in the oral cavity, pharynx, 
and esophagus. 
Th e oral phase in swallowing is voluntary and requires proper teeth to chew, a coordinated 
work of masticatory muscles and the tongue, and enough saliva to prepare the ingested material 
to be swallowed. At the end of the oral phase, the tongue pushes the bolus to the hard palate, 
which triggers the complex, refl ector, involuntary pharyngeal phase of swallowing (Figure 1). 
Elevation of the soft  palate and contraction of the posterior wall of the nasopharynx prevent nasal 
regurgitation (Ekberg 2012). Th e upward and forward movement of the larynx by suprahyoid 
muscles, the epiglottis bending backward, and the approximation of the vocal cords prevent food 
from being aspirated into the trachea. When the cricopharyngeus muscle, the physiological UES, 
relaxes while the larynx is moving up and forward, the striated pharyngeal muscles contract 
and the bolus is allowed to enter the esophagus. Th e involuntary upper esophageal muscles 
contractions drive the bolus forward into the middle and distal esophagus. As the LES relaxes, 
the involuntary esophageal phase of swallowing ends, when the bolus reaches the stomach. 
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Figure 1 Th e phases of swallowing and the cranial nerves related to the swallowing process. Th e 
fi gure is customized and translated from the article Aaltonen L-M et al. “Dysfagia – 
moniammatillinen haaste”, Duodecim 2009;125:1535-44, with permission of Duodecim. 
2.2.3 ETIOLOGY
2.2.3.1 Oropharyngeal dysphagia
In oral dysphagia, the formation of the food bolus in the mouth is impaired or the patient is 
unable to pass the bolus into the pharynx. Patients with oral dysphagia have a prolonged 
masticatory and oral transit time, they require increased amount of swallows to pass the bolus 
to the pharynx and the food may regurgitate into the nasopharynx (Sebastian et al. 2015). 
Defects in teeth or dentures and xerostomia may impair the oral phase  (Vainshtein et al. 2015). 
Moreover, Bell’s palsy, aff ecting the VII cranial nerve, may weaken the oral closure causing oral 
dysphagia. In pharyngeal dysphagia, the swallow refl ex is absent or comes with a delay, so the 
patient may aspirate. Tumors in the oral cavity or in the oropharynx and larynx may cause oral 
and oropharyngeal dysphagia, respectively. Malignant tumors oft en also present other symptoms 
and signs, such as pain, bleeding, or unhealed mucosal lesions. In addition, operations, chemo- 
and radiation therapies of malignant oral, oropharyngeal, and laryngeal tumors may impair 
swallowing.
Stroke is the most common cause for oropharyngeal dysphagia, reportedly prevalent in up 
to 81% of stroke patients (Meng et al. 2000, Cook 2008). Cerebral, cerebellar, and brain stem 
strokes may lead to dysphagia  (Martino et al. 2005). However, many other neurological disorders 
may cause dysphagia: Parkinson’s disease, myasthenia gravis, and motor neuron diseases, such as 
amyotrophic lateral sclerosis (Petit et al. 2012, Owolabi et al. 2014, Rajaei et al. 2015, Tabor et al. 
2016). In degenerative diseases, like Alzheimer’s disease, swallowing is frequently impaired as 
the disease progresses (Secil et al. 2016). Pharmacological agents, such as benzodiazepines and 
neuroleptic drugs, may alter the neuromuscular function of the oropharynx (Ebadi et al. 1990). 
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- Lips closure (VII) 
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Pharyngeal phase 
(involuntary) 
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movements (X) 
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Moreover, patients with disorders of the nervous system due to head injury or nerve damage 
aft er head and neck surgery may have swallowing diffi  culties. 
Anatomically, the pharyngoesophageal segment consists of the inferior pharyngeal 
constrictor, the cricopharyngeus muscle and the proximal part of the cervical esophagus. 
Th e UES, also called the pharyngoesophageal segment, is a functional segment. Th e UES is a 
2.5–4.5 cm high-pressure zone between the pharynx and the esophagus and may be visualized 
with manometry. Th e UES may open inadequately, causing pharyngeal dysphagia. Th e 
cricopharyngeus muscle, being 1-2 cm, is the only portion of the UES which actively participates 
in refl exive relaxation and tightening (Kuhn & Belafsky 2013). Cricopharyngeus muscle spasm 
was fi rst described back in 1950 (Asherson 1950). However, cricopharyngeal dysfunction, as a 
cause for dysphagia, may be due to reduction of the maximal opening, as well as incoordination 
(Shaker et al. 2012).
Th ere is no consensus regarding what leads to the Zenker’s diverticulum formation, but 
a diminished upper esophageal sphincter opening, increased hypopharyngeal pressure, and 
diminished wall compliance during swallowing are possible causes (Cook et al. 1992). Zenker’s 
diverticulum locates in the upper third of the esophagus where mucosa protrudes through the 
Killian’s triangle, an area of relative muscular weakness. Patients with Zenker’s diverticulum 
suff er from dysphagia, regurgitation, and halitosis. Zenker’s diverticulum comprises 70% of 
diverticula of the esophagus, with an estimated prevalence of 0.01%-0.11% (Ferreira et al. 2008).
2.2.3.2 Esophageal dysphagia
Th e cause of esophageal dysphagia is either structural or functional. Th e most common cause 
for esophageal dysphagia is GERD, with swallowing diffi  culties aff ecting up to 11% of GERD 
patients (Watson & Lally 2009). In a systematic review, GERD’s prevalence was 10-20% in the 
Western world and 5% in Asia (Dent et al. 2005). Untreated acid-GERD in particular may lead 
to development of a peptic stricture in the lower esophagus causing dysphagia  (van Boeckel & 
Siersema 2015). Gastroesophageal refl ux may damage the distal esophagus and cause intestinal 
metaplasia. Th is Barrett’s mucosa, with the possible coexistence of other risk factors such as 
cigarette smoking, alcohol consumption and obesity, has an increased risk of progression to 
dysplasia and further to adenocarcinoma, one cause of esophageal dysphagia  (Drahos et al. 
2016). In addition, an extraesophageal process may also cause a mechanical obstacle in the 
esophagus. An enlarged goiter, an aortic aneurysm, and tumors in the mediastinum or in the 
bronchus may compress the esophagus, causing dysphagia. 
Eosinophilic esophagitis is an increasing chronic infl ammatory disease with eosinophilic 
infi ltration in the esophageal epithelium (Attwood et al. 1993, Dellon et al. 2013). It is evident 
in 10% of dysphagia patients with endoscopically normal mucosa (Prasad et al. 2007). Also, the 
esophageal web, a thin membranous tissue protruding into the lumen of the cervical esophagus, 
and the Schatzki ring in the lower part of the esophagus may be structural causes for swallowing 
diffi  culties (Sreenivas et al. 2002). When a patient’s symptoms arise rapidly, a foreign body should 
be considered. Infections, such as candida and herpes, in the esophagus are also possible causes, 
especially in immune-compromised patients. 
Aft er GERD, esophageal motor disorders are the next most common cause of functional 
esophageal dysphagia. A motor disorder may be spastic, with increased esophageal body 
contractions, or there may be esophageal hypomotility, characterized by an absence or reduction 
of esophageal contractions (Valdovinos et al. 2014). Achalasia is a primary esophageal motor 
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disorder involving insuffi  cient LES relaxation and an aperistaltic esophagus which leads to 
esophageal dilatation, poor LES opening and esophageal emptying (Vaezi & Richter 1999). It 
is characterized by selective inhibitory neuron loss in the esophageal wall (Vaezi et al. 2013). 
Achalasia should be suspected if a patient has diffi  culties swallowing solids and liquids, has 
regurgitation of food and saliva, and suff ers from chest pain (Vaezi & Richter 1999). 
Distal esophageal spasm, previously called diff use esophageal spasm, is a rare, primary 
esophageal motor disorder with simultaneous, rapid contractions causing dysphagia and 
chest pain (Pandolfi no et al. 2011). Jackhammer’s esophagus is a hypercontractile esophageal 
motor disorder in which a patient may feel the esophagus moves like a jackhammer (Kahrilas 
et al. 2015). Several reports have noted that GERD, distal esophageal spasm, and jackhammer’s 
esophagus may progress to achalasia in some patients, suggesting that diff erent motor disorders 
comprise a spectrum rather than unique, stable conditions (Smart et al. 1986, Anggiansah et al. 
1990, Robson et al. 2000, Usai Satta et al. 2004).
2.2.4 DYSPHAGIA PATIENT’S EXAMINATIONS
2.2.4.1 History and physical examina? on
With careful patient history taking, it is possible to identify the cause of the dysphagia in 80-85% 
of cases (Spieker 2000). Th e main issue is to localize the dysphagia in either the oral, pharyngeal, 
or esophageal phase. Moreover, the onset, severity, and possible co-existing symptoms indicate 
the diagnosis. A patient’s medication may have possible side eff ects, like xerostomia. ENT status 
including nasolaryngoscopy, neck palpation, and cranial nerve function testing concerning 
deglutition (Figure 1) are included in the examination of a patient with oropharyngeal dysphagia. 
Th e 100 mL water swallow test is an easy outpatient examination to perform for a patient if 
aspiration is suspected. Th e test is failed if the patient coughs, is unable to fi nish the task or the 
voice becomes wet aft er drinking (Brodsky et al. 2016).
2.2.4.2 Videofl uorography
Videofl uorography has been the mainstay for evaluation of oropharyngeal dysphagia for decades. 
It has been adapted from the barium swallow, a radiographic examination of the pharynx and 
the esophagus. Logeman (1983) modifi ed this examination with liquid and solid to identify the 
cause for swallowing diffi  culties. In videofl uorography, esophageal structural abnormalities, 
such as Zenker’s diverticulum and strictures, are well diagnosed (Figure 2). Moreover, it enables 
evaluation of the swallowing process, including cricopharyngeus muscle function, and reveals 
possible aspiration. 
Th e movement of the contrast medium allows for detection of esophageal motor 
abnormalities in videofl uorography. Aperistalsis, esophageal dilation, minimal LES opening, and 
poor esophageal emptying in videofl uorography indicate achalasia (Vaezi & Richter 1999). 
2.2.4.3 Fiberop? c endoscopic evalua? on of swallowing
Aft er the fi beroptic laryngoscope became available, Langmore developed the fi beroptic 
endoscopic evaluation of swallowing (FEES) examination  (Langmore et al. 1988). FEES 
includes a physical examination of the oropharynx and the larynx, including assessing structural 
movements, and evaluation of the deglutition process with diff erent liquids and solids. In 
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addition, during the examination the patient is instructed to facilitate the deglutition with dietary 
and behavioral habits. In 1998, Aviv et al. (1998) introduced fi beroptic endoscopic evaluation of 
swallowing with sensory testing (FEESST), but this has not been widely used. 
FEES has become another gold standard examination in the assessment of oropharyngeal 
dysphagia. Studies show that FEES is even better than videofl uorography in evaluation of 
pharyngeal stasis, laryngeal penetration and aspiration, eff ective cough refl ex, and velopharyngeal 
incompetence  (Langmore et al. 1991, Wu et al. 1997). However, in FEES, esophageal structural 
and functional abnormalities are not evident, but since FEES is usually performed together with 
an ENT physician, or a phoniatrician and an SLP, it is more valuable for patient instruction. 
2.2.4.4 Endoscopy
Endoscopy, either EGD or TNE, is recommended as a fi rst-line examination when a patient with 
esophageal dysphagia has alarming symptoms, such as weight loss and food impaction in the 
esophagus, to rule out malignancy (Katz et al. 2013). During a diagnostic EGD, it is also possible 
to manage the cause of dysphagia, such as a stricture, in the same procedure with a balloon 
dilatation. A dysphagia patient’s endoscopy should also include biopsies from the middle of the 
esophagus to exclude eosinophilic esophagitis (Ferguson & Foxx-Orenstein 2007, Prasad et al. 
2007).
2.2.4.5 Manometry
Esophageal manometry is the gold standard to diagnose intraluminal esophageal pressures, 
peristalsis, and bolus transit. Previously, conventional manometry using 5 to 8 water-perfused 
channels with or without a measurement of continuous LES pressure was the diagnostic tool. 
In the 1990s, HRM was developed with up to 36 sensors, describing the bolus movement more 
accurately. HRM also identifi es those esophageal motor dysfunctions which are not detectable 
in other investigations, including conventional manometry and videofl uorography. HRM is 
performed in supine patients using a transnasally-placed solid-state catheter (Fox et al. 2004). 
In achalasia, HRM establishes the diagnosis, showing esophageal aperistalsis and insuffi  cient 
LES relaxation. However, patients should also undergo endoscopy to exclude a tumor at the 
gastroesophageal junction causing pseudoachalasia (Vaezi & Richter 1999). To unify the 
diagnostics, the Chicago Classifi cation is currently used to defi ne major and minor esophageal 
motor disorders (Kahrilas et al. 2015).
2.2.4.6 pH monitoring and 24-hour mul? channel intraluminal impedance
Esophageal pH monitoring has been the premier investigation in GERD diagnostics 
(Bollschweiler et al. 1993). Currently, combined pH monitoring with impedance allows for 
detection of acid, weakly acid, and non-acid refl ux, as well as aerophagia and mixed-refl uxiates. 
Th e addition of impedance to the pH monitoring increases the identifi cation of patients whose 
refl ux symptoms are caused by refl ux (Bredenoord et al. 2006). In a small case-control study, 
impedance also had the ability to measure the esophageal bolus transit time and stasis in 
dysphagia patients with an esophageal motor disorder (Bogte et al. 2015). Consequently, aft er 
patients with esophageal dysphagia have undergone endoscopy and manometry and aft er a 
tumor, eosinophilic esophagitis, and achalasia are excluded, pH monitoring with 24-hour MII 
may be helpful.
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2.2.5 DYSPHAGIA PATIENT’S TREATMENT
Acute stroke patients’ dysphagia symptoms oft en resolve during rehabilitation, but some patients 
remain with permanent deglutition diffi  culties (Mann et al. 1999). An SLP may instruct a patient 
with neurogenic dysphagia to eat safely and effi  ciently with the guidance of dietary modifi cations 
and behavioral strategies. However, in some patients, an oral diet is not safe enough and a feeding 
tube is required or a percutaneous gastrostomy, either temporarily or permanently. 
Botulinum toxin injections to cricopharyngeus muscle are a safe and eff ective treatment 
for cricopharyngeus muscle spasm and hypertonicity  (Blitzer & Brin 1997, Ahsan et al. 2000, 
Haapaniemi et al. 2001). Moreover, balloon catheter dilatation and laser myotomy are benefi cial 
to enhance the cricopharyngeus muscle opening (Arenaz Bua et al. 2015). Esophageal strictures 
can be dilated with the balloon as well (van Boeckel & Siersema 2015). Additionally, balloon 
dilatation is considered a simple outpatient procedure having the least morbidity in the 
management of a cervical esophageal web (Sreenivas et al. 2002). For many years, the choice of 
treatment for Zenker’s diverticulum was an open surgical diverticulectomy with cricopharyngeal 
myotomy. Nowadays, however, an endoscopic staple-assisted esophagodiverticulostomy (Figure 
2) is oft en preferred since it is safe and eff ective, with a shorter operation time and hospital stay 
and leads to quicker oral intake (Richtsmeier 2003, Bonavina et al. 2012).
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Figure 2 Zenker’s diverticulum visualized in videofl uorography (left  image), and in rigid endoscopy 
before the endoscopic staple-assisted esophagodiverticulostomy (right image). Pictures: 
Leena-Maija Aaltonen.
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Empiric PPI therapy is recommended as a fi rst-line trial to diagnose possible GERD 
in patients with typical symptoms: heartburn and regurgitation (Katz et al. 2013). Dysphagia 
resolves in patients with esophagitis during PPI medication (Vakil et al. 2004). For patients with 
a partial response to a once-daily dose, a twice-daily dose should be considered. Non-responders 
to PPI should be referred for further evaluation (Katz et al. 2013). 
In achalasia, the two most eff ective treatment options are pneumatic dilation and surgical 
myotomy, the latter originally created by Heller (Heller 1913, Vaezi & Richter 1999, Wauters et 
al. 2014). However, for patients at high risk for complications due to the procedures, endoscopic 
injections of the LES with botulinum toxin or pharmacological treatment with nitrates or 
calcium channel blockers are alternatives (Vaezi & Richter 1999). Historically, distal esophageal 
spasm has been treated with these medications as well, with only a limited benefi t, however. 
Also, endoscopic treatment with botulinum toxin injections and myotomy has been proposed, 
but further investigation is needed (Roman & Kahrilas 2015). Pharmacological treatments and 
pneumatic dilatation have been used in the treatment of jackhammer’s esophagus, but further 
investigations are required (Jia et al. 2016). Surgical treatment is recommended for esophageal 
cancer, when possible. Based on a Cochrane database systematic review, in chemoradiotherapy, 
the short-term and long-term survival seems to be at least equivalent to surgery in patients 
with squamous cell esophageal carcinoma (Best et al. 2016). However, in adenocarcinoma, the 
comparison of signifi cant benefi ts and harms between defi nitive chemoradiotherapy and surgical 
treatment has been unable to be assessed (Best et al. 2016).
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3 AIMS OF THE STUDY
Th e general objective of this thesis was to study the etiology of globus, to update the diagnostics 
of globus and dysphagia, and to clarify the natural course of these symptoms. Th e specifi c aims 
were to:
1. Investigate the possible esophageal background of globus with TNE, HRM, and 24-h 
MII-pH (I).
2. Evaluate whether globus patients’ symptoms are relieved in the short term and if voice 
problems are associated with globus (II).
3. Determine whether radiographic examinations are useful in globus diagnostics (III).
4. Investigate how globus and dysphagia symptoms alter in the long term and whether 
these conditions are an early symptom of malignancy (III, IV).
Aims of the Study
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4 SUBJECTS AND METHODS
4.1 PATIENTS AND CONTROLS
4.1.1 STUDY I, II
We prospectively recruited 30 consecutive globus patients (67% female; median age 45, range 
22-67) referred to the Helsinki University Hospital (HUH), Department of Otorhinolaryngology 
– Head and Neck Surgery between November 2011 and October 2013. Th ose who were previously 
examined in our clinic due to globus or were under 18 or over 75 years old were excluded. 
Referrals of globus patients with dysphagia, hoarseness, odynophagia, a diagnosis of rheumatoid 
arthritis, or head and neck malignancies were also excluded. Furthermore, two patients were 
excluded from the fi nal analysis: one refused the study aft er her initial visit, the other also had 
throat pain and the ENT examination revealed a soft -palate tumor which was later diagnosed as 
a squamous cell carcinoma. Patients’ general heath was assessed using the Charlson Comorbidity 
Index (CCI) (Charlson et al. 1987). Th e CCI is a tool to evaluate a patient’s possible comorbid 
conditions, such as diabetes and chronic pulmonary disease, which may alter the patient’s risk of 
mortality. Th e CCI can be adjusted by age.
In study I, controls were prospectively recruited from 24 patients (67% female; median age 
57, range 19-75) who were referred for an operative evaluation in the Department of Abdominal 
Surgery at HUH between May 2013 and May 2014 due to diffi  cult refl ux symptoms.
4.1.2 STUDY III, IV
In these retrospective studies, we extracted from the hospital database all patients referred to 
our department in HUH in 2009 due to globus (III) and dysphagia (IV) using the International 
Statistical Classifi cation of Diseases 10th edition (ICD-10) codes F45.8 and R13, respectively. Th e 
globus (III) and dysphagia (IV) diagnoses were confi rmed by reviewing patients’ clinical data. In 
study III, the CCI was used to determine the patients’ general health.
4.2 METHODS
4.2.1 INVESTIGATIONS ?I, II?
4.2.1.1 Clinical ear, nose, and throat examina? on and videolaryngoscopy (II)
All 30 globus patients underwent a clinical ENT examination including neck palpation and 
videolaryngoscopy at their initial visit. Subsequently, each videolaryngoscopy was scored using 
the Refl ux Finding Score (RFS) (Appendix 1), an eight-item clinical severity scale where seven 
points or more are considered to be suggestive for LPR (Belafsky et al. 2001). 
4.2.1.2 Transnasal esophagoscopy and esophagogastroduodenoscopy (I)
Aft er informed consent, the patient underwent TNE (Olympus GIF-XP180N). Local anesthesia 
was used prior to the procedure, with two sprays of lidocaine (10%) to the nasal cavity and 
then with a 1% lidocaine cum adrenalin-moistened cotton swab placed in the nasal cavity for 
10 minutes. No premedication was used. Lidocaine gel (2%) functioned as a lubricant on the 
endoscope when it was placed transnasally while the patient was sitting in front of the clinician. 
At fi rst, the nasopharynx, hypopharynx, and larynx were investigated and then the endoscope 
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was passed into the esophagus. Th e TNE was performed by an otorhinolaryngologist and a 
gastroenterologist and included examination of the esophagus, stomach and the beginning of 
the duodenum. Biopsies were taken from the hypopharynx, the middle and lowest part of the 
esophagus, as well as from the antrum and corpus of the stomach.
All 24 controls underwent EGD either before the referral or at the Department of Abdominal 
Surgery. If biopsies were taken, they were from the lowest part of the esophagus and the antrum 
and corpus of the stomach. 
In TNE and EGD, hiatal hernia and a loose lower esophageal sphincter were clinical 
diagnoses. Possible endoscopic esophagitis was classifi ed according to the Los Angeles (LA) 
Classifi cation system, which includes four grades (LA A-LA D) (Lundell et al. 1999). One (or 
more) mucosal breaks that did not extend between the tops of two mucosal folds and were no 
longer than 5 mm, or were more than 5 mm long, were classifi ed as LA A and LA B esophagitis, 
respectively. According to LA Classifi cation, one (or more) mucosal breaks that are continuous 
between the tops of two or more mucosal folds, but which involve less than 75% of the 
circumference is considered to be LA C esophagitis. In LA D esophagitis, there are one (or more) 
mucosal breaks involving at least 75% of the esophageal circumference. In our study, however, 
there were no LA C or LA D esophagitis cases.
A histological diagnosis of esophagitis was made according to the generally recommended 
criteria (Genevay et al. 2010). Th e diagnosis of histological esophagitis included basal cell 
hyperplasia, papillae elongation, dilated intercellular spaces, and intraepithelial neutrophils, 
lymphocytes and possible eosinophils. However, the histological diagnosis of eosinophilic 
esophagitis would have required at least 15 eosinophils per high-power fi eld (Furuta et al. 2007). 
Th e histological diagnosis of Barrett’s esophagus required intestinal metaplasia with goblet cells 
and the same marks of infl ammation as in esophagitis. Th e antral and corpus biopsies were 
assessed separately and the histological diagnosis of gastritis was made according to a modifi ed 
Sydney classifi cation (Price 1991) including the grading of acute and chronic infl ammation, 
atrophy, intestinal metaplasia, dysplasia and Helicobacter pylori, of which the latter is evident in 
the Giemsa stain. Th e characteristics of all histologic specimens were graded from 0 to 3 (0=no 
changes, 1=mild changes, 2=moderate changes, 3=marked changes).
4.2.1.3 High-resolu? on manometry (I)
Aft er a fast of at least fi ve hours, manometric studies were performed in supine patients. 
A 36-channel solid-state catheter (ManosScan 360, Given Imaging, Los Angeles, CA) was 
positioned transnasally. Aft er a 5-min baseline recording, 10 x 5 mL water was given with a 
syringe. Using the Manoview ESO 3.01 program (Given Imaging, Duluth, CA), the swallow 
response was determined according to the Chicago classifi cation  (Bredenoord et al. 2012).
4.2.1.4 24-hour mul? channel intraluminal impedance and pH monitoring (I)
Aft er manometry, combined MII-pH monitoring was performed with a ZepHr recorder 
(Sandhill Scientifi c Inc, Highlands Ranch, CO). Th e single-use catheter was placed transnasally: 
one pH electrode 5 cm above the proximal border of the LES and six impedance segments 3 to 17 
cm above the LES. Patients were advised to keep records of their upright or recumbent position, 
meal times, and possible symptoms during ambulatory monitoring for the next 24 hours. 
An acid-refl ux episode was determined with a pH nadir <4, otherwise it was recorded 
as non-acid. In pH monitoring, the DeMeester score, indicating the overall pH score, was 
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calculated. Th e normal value of the DeMeester score was < 14.7. A supragastric belch was 
determined as a rapid antegrade movement of gas (≥1000 Ω) followed by a quick expulsion of 
gas in the retrograde direction, resulting in a return to baseline impedance level in the retrograde 
direction (Kessing et al. 2012). According to a previous study, 50% of healthy volunteers had 
a median of two (IQR 1-6) supragastric belches (Hemmink et al. 2009a). In this study, over 
six supragastric belches during a 24-hour measurement were considered to be a pathological 
amount. Air swallow was determined as a swallow with an impedance increase of 1000 Ω or 
more in the most distal recording segment  (Hemmink et al. 2009b).
In the MII-pH monitoring, a catheter was fi xed at the LES, however, a catheter with two 
fi xation points was unavailable at the time the procedures were performed. Consequently, the 
proximal measuring point varied between patients. Because proximal refl ux events are reported 
in approximately 50% of the distal refl ux events, we considered a reference value for proximal 
refl ux events as being more than 36 refl ux episodes, which is half of the reference value of distal 
refl ux events (73) (Shay et al. 2004).
4.2.1.5  A speech and language pathologist’s examina? on (II)
Aft er a four-month follow-up, an SLP interviewed and examined the globus patients. Before 
the appointment, the patients fi lled in the Refl ux Symptom Index (RSI) (Appendix 2), the 
Deglutition Handicap Index (DHI) (Appendix 3) and the 15-Dimensional Measure of Health-
Related Quality of Life (15-D) (Appendix 4). Th e SLP’s examination included an evaluation 
of vocal quality and the ability to control the pitch and loudness of the voice. Th e maximum 
phonation time was measured using /a/ and /s/. For women, the reference value of the maximum 
phonation time is 15-25 s and 25-35 s for men  (Hirano 1981).
4.2.2 QUESTIONNAIRES ?II, III, IV?
4.2.2.1 The Refl ux Symptom Index (II)
Th e RSI is a nine-item questionnaire of symptoms possibly related to LPR  (Belafsky et al. 2002). 
Th e point scale ranges from 0 to 5, and a total score over 13 is considered abnormal. In study II, 
the globus patients fi lled in the RSI at their initial visit at the ENT clinic and again at the four-
month follow-up with the SLP. 
4.2.2.2 The Deglu? ? on Handicap Index (II, III, IV)
Th e DHI is a self-administered quality-of-life questionnaire related to deglutition  (Woisard 
& Lepage 2010). It is divided into three subscales—physical, functional, and emotional—of 10 
questions each. Th e point scale ranges from 0 to 4, maximum 120 points. A total score over 20 
and/or 9 points or more in a single subscale is considered abnormal. 
In study II, globus patients completed the DHI at the initial visit and at the four-month 
follow-up with the SLP. 
In studies III and IV, the DHI was included in the follow-up questionnaires sent to the 
patients three (III, IV) and again six (III) years aft er the initial visit. Th e questionnaire also 
included a question asking whether the patient still had globus (III) or dysphagia (IV) symptoms. 
Th e questionnaire was only sent if the patient’s native language was Finnish or Swedish and if the 
patient was alive based on the Population Registry. Th e three-year follow-up questionnaire was 
sent in December 2012 and, if needed, a reminder was sent in February 2013 (III, IV). Th e six-
Subjects and Methods
30
year follow-up questionnaire was sent in October 2015 and with a reminder in November 2015, 
if the patient had not responded (III).  
In studies II, III, and IV, we used the DHI translated into Finnish and Swedish (Aherto & 
Vilkman 2008).
4.2.2.3 The 15-Dimensional Measure of Health-Related Quality of Life (II)
Th e 15-D is a self-administered health-related quality of life instrument consisting of 15 
dimensions: mobility, vision, hearing, breathing, sleeping, eating, speech, excretion, usual 
activities, mental function, discomfort and symptoms, depression, distress, vitality, and sexual 
activity. In each dimension, the respondent chooses one of fi ve levels to describe his or her 
present health status.   Th e 15-D supplies a 15-dimensional profi le and a single utility score 
between 0 (equivalent to being dead) and 1 (full health) (Sintonen 2001). In the 15-D score, the 
minimal clinically important change or diff erence is reported to be 0.015 (Alanne et al. 2015). 
Th e National Health 2011 Survey provided the representative population sample, which was 
standardized for age (Koskinen et al. 2012). 
In study II, the 15-D was the third questionnaire that the globus patients fi lled in at the 
initial visit and at the four-month follow-up.
4.2.3 MEDICAL RECORDS ?III, IV?
Aft er identifying globus (III) and dysphagia (IV) patients from the hospital database, we surveyed 
patients’ records and registered medical data: age, gender, symptoms and fi ndings at clinical ENT 
examination and possible further examinations (neck ultrasound, videofl uorography, FEES, 
TNE, EGD, HRM, 24-h MII-pH). Based on the data, the suspected cause of the globus (III) and 
dysphagia (IV) symptoms was reviewed. 
4.2.4 THE FINNISH CANCER REGISTRY DATA ?III, IV?
We surveyed the Finnish Cancer Registry (FCR) data, which clarifi ed all the globus (III) and 
dysphagia (IV) patients’ cancer diagnoses until the end of 2012. We recorded cancer diagnoses 
from the head and neck area and the aerodigestive track, of which globus or dysphagia could 
have been an early symptom.
4.3 STATISTICAL ANALYSIS
In study I, the estimated prevalence of acid refl ux determined the sample size: 25% in globus 
patients and 75% in controls. Th e sample size was calculated to be 16 patients. Subsequently, 20 
patients were selected to both groups. Th e confi dence interval was set at 95% (α=0.05 and β=0.1). 
Either chi-square or Fisher’s exact tests were used for comparisons of categorical variables 
between globus patients and controls, and the Mann-Whitney U test was used for comparisons 
of non-normally distributed continuous variables between globus patients and controls.
In study II, diff erences in globus patients’ RSI and DHI between the initial visit and at the 
four-month follow-up were performed using the Wilcoxon signed-rank test. Diff erences in the 
15-D, compared to those of the general population, were determined by the Mann-Whitney U 
test and diff erences between globus patients’ 15-D baseline and four-month follow-up results 
were determined by the Wilcoxon signed-rank test.
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In studies III and IV, diff erences in the age distributions between genders were determined 
with the independent samples t test, as were diff erences in age between respondents and non-
respondents. Diff erences in gender distributions between respondents and non-respondents, 
however, were determined by the Pearson chi-square test. In study III, the globus patients’ DHI 
diff erences and the self-ratings regarding present globus symptoms between the three and six 
year follow-ups were analyzed using the Wilcoxon signed-rank test. Th e globus self-ratings 
between those who had a specifi c cause for globus and those who did not were compared using 
the chi-square test. In study IV, the diff erence in the distributions of diagnoses between those 
returning and not returning the questionnaire was examined using the Mann-Whitney U test.  
P-values were all two-tailed and the signifi cance level was set at 0.05. All computations were 
performed using the Statistical Program for Social Sciences (SPSS for Windows, Version 22.0 
statistical soft ware; SPSS Inc, Chicago, IL, USA). 
4.4 ETHICAL CONSIDERATIONS
Th e Ethics Committee of the Department of Surgery of the Helsinki and Uusimaa Hospital 
District approved all the study protocols. In studies I and II, the patients provided written 
informed consent before enrollment into the study. In studies III and IV, patients receiving the 
questionnaires were informed about the study protocol and that their confi dential answers would 
be used in our research. 
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5 RESULTS
5.1 EXAMINATIONS ?I, II?
5.1.1 TRANSNASAL ESOPHAGOSCOPY ?I?
TNE was performed on all 30 globus patients. However, we only had HRM and 24-h MII-pH 
monitoring results from 20 patients: 9 patients refused HRM and 10 patients refused 24-h 
MII-pH monitoring aft er the TNE. Age and gender distributions did not diff er between those 
who underwent all investigations compared to those who did not. All 24 controls underwent 
EGD, HRM, and 24-h MII-pH monitoring. Globus patients were not on PPIs when participating 
in the study. Controls, on the other hand, did experience heartburn, despite their use of regular 
PPI medication but they did not have any globus symptoms.
TNE was macroscopically normal in globus patients more oft en than EGD in controls 
(P<0.001) (Table 1). Moreover, hiatal hernia was evident more oft en in controls than in globus 
patients (P<0.001) (Table 1). Some globus patients and controls had LA A or LA B esophagitis, 
but with regards to prevalence, no statistically signifi cant diff erences were seen (Table 1). Biopsies 
revealed histologically mild esophagitis in the lowest and/or middle part of the esophagus in 
globus patients more oft en, but this diff erence did not reach statistical signifi cance (Table 1). 
Table 1. Endoscopic and histologic fi ndings from transnasal esophagoscopy and 
esophagogastroduodenoscopy (study I).
 
 Globus, 
n=30
Controls, 
n=24  
Findings from TNE / EGD n (%) n (%) P value
   Esophagitis 3 (10.0) 6 (25.0) 0.165
   - LA A esophagitis 1 (3.3) 3 (13.0) 0.312
   - LA B esophagitis 2 (6.7) 3 (13.0) 0.646
   Barrett’s esophagus 1 (3.3) 1 (4.2) 1.000
   Suspicion of gastritis 2 (6.7) 0 0.495
   Hiatal hernia 0 23 (96.0) <.001
   Loose lower esophageal sphincter 1 (3.3) 2 (8.3) 0.585
   No fi ndings 14 (47.0) 0 <.001
 
Globus, 
n=29
Controls, 
n=18  
Histological fi ndings n (%) n (%) P value
   Mild esophagitis in lowest/middle part of esophagus 10 (34.0) 4 (22.0)* 0.516
   H.pylori infection and mild active gastritis in corpus 1 (3.4) 0 1.000
   Mild chronic gastritis in corpus 1 (3.4) 1 (5.6) 1.000
   Mild/moderate gastric metaplasia in lowest part of
   esophagus 2 (6.9) 1 (5.6) 1.000
   Mild intestinal hyperplasia in antrum 0 1 (5.6) 0.383
   Barrett’s esophagus (intestinal metaplasia) 1 (3.4) 0 1.000
   Mild infl ammation in hypopharynx 2 (6.9)    
* ulcerative esophagitis in one patient 
TNE=transnasal esophagoscopy, EGD=esophagogastroduodenoscopy, LA=the Los Angeles Classifi cation system 
for endoscopic appearance for erosive esophagitis, H.pylori=Helicobacter pylori
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5.1.2 HIGH?RESOLUTION MANOMETRY ?I?
We had HRM results from 21 globus patients and 24 controls. In HRM, the UES basal and 
residual pressures were not elevated in globus patients, and no statistically signifi cant diff erence 
was seen between globus patients and controls (Table 2).
Based on Chicago Classifi cation version 2.0 criteria (Bredenoord et al. 2012), esophageal 
motility was normal in 8 globus patients (38.1%) and in 12 controls (50%). In both globus 
patients and controls, 11 individuals (52.4% and 45.8%, respectively) had minor motor disorders 
evident in HRM. Moreover, two globus patients (9.5%) and one control (4.2%) had a major 
motor disorder diagnosed. Globus patients’ major motor disorders were absent peristalsis 
and esophagogastric junction (EGJ) outfl ow obstruction. Th e major disorder for control was 
jackhammer’s esophagus. Diff erences in fi ndings between globus patients and controls regarding 
esophageal motility were statistically non-signifi cant.
5.1.3 24?HOUR MULTICHANNEL INTRALUMINAL IMPEDANCE AND pH 
MONITORING ?I?
All results from the 24-h MII-pH were available of 20 globus patients and 23 controls. One 
control’s esophageal mucous membrane was in poor condition because of refl ux and therefore 
his 24-h MII could not be analyzed. According to pH monitoring, the DeMeester scores and 
total time at pH < 4 were higher in controls (P<0.001). Also, the total refl ux time for controls 
was longer (P=0.004) and they had more acid refl ux (P=0.002) in MII. Controls had pathological 
total proximal refl ux events more oft en (9/23, 39% vs. 1/20, 5%; P=0.01). Th e one globus patient 
who had a pathological amount of total proximal refl ux events (n=53) also had a prolonged total 
refl ux time (2.2%) in MII. Aft erward, she reported that she had also suff ered from heartburn. 
However, we did not exclude this patient from the fi nal analysis. Regarding non-acid refl ux, no 
statistically signifi cant diff erence was evident between globus patients and controls. Detailed 
results from the 24-h MII-pH monitoring are presented in Table 2. 
MII revealed that globus patients had supragastric belching more frequently than controls 
(6/20, 30% vs. 1/24, 4%; P=0.038). Moreover, aerophagia (Figure 3) was evident in globus 
patients more oft en than controls, although the diff erence was not statistically signifi cant (5/20, 
25% vs. 2/23, 9%).
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Table 2. Results from high-resolution manometry and 24-hour multichannel intraluminal 
impedance and pH monitoring (study I). 
Globus, 
n=21
Controls, 
n=24  
  Median (IQR) Median (IQR) P value
HRM      
UES      
   Mean basal pressure (mm Hg) 65.0 (56.5, 83.2) 66.0 (57.5, 74.0) 0.609
   Residual pressure (mm Hg) 4.2 (0.2, 8.4) 6.3 (3.0, 10.1) 0.116
LES      
   Mean pressure (mm Hg) 17.4 (10.6, 27.7) 14.8 (10.0, 20.0) 0.158
 
Globus, 
n=20*
Controls, 
n=24  
  Median (IQR) Median (IQR) P value
24-hour pH      
   DeMeester score 4.1 (1.0, 6.6) 14.4 (4.3, 27.9) <.001
   Total time pH < 4 (%) 0.8 (0.1, 1.6) 4.1 (1.0, 8.7) <.001
 
 
Globus, 
n=20*
Controls, 
n=23**  
  Median (IQR) Median (IQR) P value
MII      
   Total refl ux time (%) 0.8 (0.5, 1.3) 1.5 (1.1, 2.5) 0.004
   Acid refl ux events 15.5 (8.5, 26.5) 35.0 (25.0, 56.0) 0.002
   Non-acid refl ux events 20.5 (9.8, 26.8) 22.0 (9.0, 35.0) 0.443
* one globus patient did not undergo 24-hour pH or MII aft er HRM   
** one control’s MII was uninterpretable because of the poor condition of the esophageal mucous mem-
brane 
HRM=high-resolution manometry, UES=upper esophageal sphincter, LES=lower esophageal sphincter, 
MII=multichannel intraluminal impedance, IQR=interquartile range
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5.1.4 PATIENT HISTORY, EAR, NOSE, AND THROAT EXAMINATION AND 
VIDEOLARYNGOSCOPY ?II?
PPIs were prescribed to 18 (60%) globus patients before referral. However, most of them had used 
the medication only for a couple of weeks, without benefi t. Seven patients (23%) reported voice 
problems, at least sometimes, at the initial visit. Seven patients (23%) suff ered muscle tension 
in the head and neck. Th ree patients (10%) had stress. Two patients had depression and used 
selective serotonin reuptake inhibitor (SSRI) medication. One patient had a bipolar disorder. Th e 
median unadjusted and age-adjusted CCI were both 0 (ranges 0-2 and 0-3, respectively), with 
the CCI being 0 in 87% of patients.
Th e ENT examination revealed normal fi ndings in 29 patients (97%). Because of lingual 
tonsil hypertrophy, one patient underwent magnetic resonance imaging (MRI) with normal 
fi ndings. Neck palpation showed no pathological fi ndings. We scored videolaryngoscopy in 28 
patients (93%); in two cases, videos could not be interpreted. None of the patients had more than 
six points in the RFS. 
5.1.5 SPEECH AND LANGUAGE PATHOLOGIST INTERVIEWS AND 
EXAMINATIONS ?II?
Th e SLP interviewed and examined 23 (77%) patients (median age 44, range 22-67 years, and 
15 (65%) female) four months (+/-14 days) aft er their initial visit. Th ree patients (10%) refused 
the interview and examination, another four patients answered and returned the follow-up 
questionnaires, but did not meet the SLP. Based on the SLP’s interview and examination, six 
patients (26%) had functional problems with their voices. Problems were mainly associated with 
their voice quality (Table 3). Th ey all suff ered from persistent globus.  
Table 3. Results of the speech and language pathologist’s examination (study II).
 
 
Normal
n (%)
Abnormal
n (%)
Vocal quality 17 (74) 6 (26)
Control of the vocal loudness 23 (100) 0 (0)
Control of the vocal pitch 23 (100) 0 (0)
Maximum phonation time 12 (52) 11 (48)
    - /a/    
Measure of expiratory control 14 (61) 9 (39)
    - /s/    
5.2 CHANGES IN GLOBUS AND DYSPHAGIA SYMPTOMS AT 
FOLLOW?UP ?II, III, IV?
5.2.1 GLOBUS AT FOUR?MONTH FOLLOW?UP ?II?
In study II, 30 globus patients fi lled in the RSI, DHI and 15-D questions at their initial visit. 
However, at the four-month follow-up we only received questionnaires from 27 (90%) patients 
(median age 44, range 22-67), of whom 17 (63%) were female. Globus patients’ symptoms 
improved in the RSI (P=0.001) and the DHI (P=0.003) (Table 4). In the RSI, 17 (57%) patients 
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had more than 13 points at the initial visit, referring to an abnormal result. At follow-up, only 
fi ve patients’ (19%) RSI total score was elevated. In DHI, patients’ symptoms were relieved on 
the physical (P=0.018) and emotional subscales (P=0.004), but not on the functional subscale 
(Table 4). 
At the initial visit in the 15-D, globus patients had worse scores compared to an age-
matched sample of the general population on 6 of the 15 dimensions: breathing, sleeping, eating, 
discomfort and symptoms, vitality, and speech. At the four-month follow-up, globus patients had 
improved in discomfort and symptoms (P=0.023), but were more depressed (P=0.033).
Table 4. Results from the Refl ux Symptom Index and the Deglutition Handicap Index (study II). 
 
Initial visit
n=30
4 month follow-up
n=27  
  Median (range) Median (range) P value
Refl ux Symptom Index 14.0 (3-27) 9.0 (1-22) 0.001
Deglutition Handicap Index 8.5 (0-60) 6.0 (0-45) 0.003
  Physical subscale 5.5 (0-19) 4.0 (0-15) 0.018
  Functional subscale 0 (0-18) 0 (0-15) 0.419
  Emotional subscale 2.0 (0-23) 1.0 (0-15) 0.004
5.2.2 GLOBUS AT THE THREE? AND SIX?YEAR FOLLOW?UP ?III?
In 2012, at the three-year follow-up, we sent the questionnaire concerning present pharyngeal 
symptoms to 70 patients who were alive based on the Population Registry, and whose native 
language was Finnish or Swedish. One patient had deceased, three patients’ native language was 
other than Finnish or Swedish and two patients’ contact information was lacking. We received 
three-year follow-up questionnaires from 37 globus patients (53%); median age was 57.0 (range 
24-83) and 28 (76%) were female. In the DHI, the median score was 7.0 (range 0-71), with 
an elevated total DHI in six patients (17%). No globus symptoms were reported by 11 (38%) 
patients, 5 (17%) had fewer symptoms than at baseline, 11 (38%) had unchanged symptoms and 
2 (7%) had more diffi  cult symptoms. Eight patients’ answers were not interpretable or they had 
not answered that question.
In 2015, a minimum of six years aft er the initial visit, we sent the same questionnaire again, 
and received it from 27 globus patients (39%); median age was 60 (range 35-86) and 23 were 
female (85%). Th e DHI median was 5.0 (range 0-51) and the total DHI was abnormal in four 
patients (15%). Aft er six years, 12 (44%) patients had no globus symptoms anymore, two (7%) 
had less symptoms and 13 (48%) were still experiencing similar symptoms. None had worse 
symptoms.
In 2012 and 2015, age and gender distributions between responders and non-responders 
were similar. Follow-up questionnaires from both occasions were available for 22 patients. 
Between three and six years of follow-up, globus patients’ DHI scores and self-ratings regarding 
present globus symptoms were similar. Moreover, globus self-ratings were similar between those 
having a suspected identifi able cause for globus at the initial visit and all others. 
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5.2.3 DYSPHAGIA AT THE THREE?YEAR FOLLOW?UP ?IV?
Th ree years aft er the initial visit, we sent the follow-up questionnaire which included the DHI 
and a question on whether the patient had anymore dysphagia to 250 dysphagia patients. Based 
on the Population Registry, 44 patients were deceased and 9 patients’ native language was other 
than Finnish or Swedish. We received questionnaires from 154 patients (62%): 30 (19%) reported 
no symptoms, 36 (23%) had fewer symptoms than baseline, 43 (28%) had unchanged symptoms, 
and 12 (8%) had worse symptoms. Patients’ reported scores on the DHI are presented in Table 5. 
Table 5. Patients reported DHI according to diagnostic groups three years aft er the clinical visit 
(study IV). 
Diagnostic group DHI Responders
(n=questionnaires sent) Median (IQR) n (%)
Descriptive diagnosis of dysphagia (n=143) 15.0 (8.0, 29.0)  78 (55) 
GERD (n=50) 12.5 (4.0, 23.8) 28 (56)
Neurological cause (n=22) 53.0 (9.0, 62.5) 5 (23)
ZD / cricopharyngeus muscle dysfunction (n=16) 20.5 (7.8, 27.3)  10 (63)
Other cause (n=19) 17.0 (10.0, 35.3) 8 (42)
DHI=Deglutition Handicap Index, IQR=interquartile range, GERD=gastroesophageal refl ux disease, 
ZD=Zenker’s diverticulum
5.3 RESULTS FROM THE MEDICAL RECORDS ?III, IV?
5.3.1 GLOBUS PATIENTS ?III?
In 2009, a total of 76 patients were referred to our clinic because of globus. Th eir median age was 
49.5 (range 20-88) and 59 (78%) were female; age distributions were similar by gender. Eleven 
patients (14%) had a psychiatric diagnosis and SSRI medication. Of those eleven, seven patients 
had depression, one had a panic disorder and one a bipolar disorder. Two patients’ indication 
for SSRI medication was not evident. Th e median unadjusted and age-adjusted CCI were both 0 
(ranges 0-5 and 0-7, respectively), and 79% of patients had no comorbidities.
An ENT examination including neck palpation was performed on all patients. Before 
referral, 23 patients underwent neck ultrasound; additionally, ultrasound was performed at 
our department on 14 patients. One patient had a palpable goiter, which the neck ultrasound 
confi rmed. Otherwise, fi ndings from the neck ultrasound revealed no additional information 
about the possible etiology of globus. Before referral, six patients underwent gastroscopy and one 
duodenal ulcer was diagnosed. Other gastroscopies were normal. At our department, one patient 
(1%) was examined using TNE with normal fi ndings. Aft er ENT examination, 22 patients (29%) 
underwent videofl uorography. Two patients (9%) had slightly abnormal results, a minor residual 
of the contrast medium, all other examinations being otherwise normal. 
Based on a retrospective analysis of medical records, a suspected cause for globus was 
evident in 44 (58%). Dry mucous membranes were the most common cause in 13 (17%). Other 
causes were muscle tension in the neck (12, 16%), psychological cause (6, 8%), problems with 
voice (5, 7%), lingual tonsil hypertrophy (3, 4%), epiglottis in contact with adjacent structures (3, 
4%), goiter (1, 1%) and a sequela aft er acoustic neurinoma surgery (1, 1%). 
Results
38
During the outpatient visits, globus patients were mainly just advised about the symptom 
and they received support and reassurance. Patients with dry mucous membranes were instructed 
to drink enough water and humidify the inhaled air. A PPI was prescribed to 22 patients (29%) 
as a trial to diagnose possible silent refl ux, even though patients had no heartburn. To support 
smoking cessation, one patient received a bupropion prescription. Th ree patients received a 
referral to an SLP and two other patients to a physiotherapist. Th e patient having a palpable 
goiter was referred to surgical evaluation and, aft er thyroid lobectomy, her globus symptom was 
relieved. 
5.3.2 DYSPHAGIA PATIENTS ?IV?
Based on the hospital database, 303 patients (62% female, median age 64, range 19-99) with 
dysphagia symptoms were referred to our clinic in 2009. Videofl uorography was the investigation 
performed most frequently (173, 57%). Other performed investigations were FEES (55, 18%), 
neck ultrasound (36, 12%), EGD (39, 13%), manometry (9, 3%), pH measurement (4, 1%) and 
TNE (2, 1%). Most investigation fi ndings were normal (Table 6).
According to retrospective analysis of medical records, most dysphagia patients investigated 
at our ENT clinic remained with a descriptive diagnosis of dysphagia, unspecifi c dysphagia (167, 
55%). Specifi c causes for patients’ dysphagia included suspected GERD in 52 (17%), neurological 
cause in 33 (11%), and Zenker’s diverticulum or cricopharyngeus muscle dysfunction in 26 (9%) 
subjects. Dysphagia was related to sequelae of head and neck surgery or treated head and neck 
malignancies in 18 (6%) cases. Moreover, one patient had a palpable tumor in the neck that was 
later diagnosed as a goiter. A new malignant disease was diagnosed in fi ve patients. In all cases, 
the status or suspicion of malignancy was evident at the initial visit. Th ree esophageal cancers 
were diagnosed in EGD; all of these patients had progressive dysphagia with food impaction in 
the esophagus. ENT examination revealed one laryngeal and one oropharyngeal cancer. 
Most of the patients only received instructions during their clinical visit. A PPI was 
prescribed to 86 (28%) patients, 49 patients (16%) were referred to an SLP, and 7 (2%) to a 
physiotherapist. An endoscopic diverticulectomy with stapler was performed on four patients 
with Zenker’s diverticulum. One patient with cricopharyngeal muscle dysfunction underwent 
cricopharyngeal myotomy and another underwent esophageal dilatation. Percutaneous 
endoscopic gastrostomy was performed on two patients. 
Table 6. Examinations performed to dysphagia patients in 2009 (study IV).
Examination
 
Normal
n (%)
Abnormal
n (%)
Not done
n (%)
Videofl uorography 117* (38) 56 (18) 130 (43)
Neck ultrasound 26 (9) 10 (4) 267 (88)
FEES 25 (8) 30 (10) 248 (82)
Esophagogastroscopy 23 (8) 16 (5) 264 (87)
TNE 2 (1) 0 (0) 301 (99)
Manometry 6 (2) 3 (1) 294 (97)
pH  measurement 3 (1) 1 (0) 299 (99)
* Includes 44 patients with slight abnormalities.
FEES=fi beroptic endoscopic evaluation of swallowing, TNE=transnasal esophagoscopy
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5.4 THE FINNISH CANCER REGISTRY DATA ?III, IV?
In study III, the FCR data confi rmed that during the three-year follow-up from 2009 to 
2012, none of the globus patients developed malignancy in the head and neck area or in the 
aerodigestive track, of which globus could have been an early sign at the initial visit in 2009. 
In study IV, based on the FCR data, none of the dysphagia patients had a new diagnosis of 
malignancy in the head and neck area or in the aerodigestive tract, which would not have already 
been identifi able in 2009.
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6 DISCUSSION
Th is thesis aimed to investigate the possible esophageal background of globus, to clarify globus 
and dysphagia diagnostics and to present the natural course of these symptoms and their potential 
as an early sign of malignancy. Our results indicate that globus patients without refl ux symptoms 
did not have acid or non-acid GERD, their UES pressure was normal and major esophageal motor 
disorders were uncommon. However, supragastric belching was evident in globus patients more 
oft en than in controls with refl ux symptoms. Th e three- and six-year follow-ups showed that 
some patients may suff er from persistent globus. However, the FCR data confi rmed that globus 
was not an early sign of malignancy at the three-year follow-up. Many swallowing diffi  culties 
were mild and no specifi c diagnosis could be assessed. Dysphagia patients who did not suff er 
from alarming signs or whose ENT status was normal did not develop a malignancy at the three-
year follow-up. Th is study emphasizes the need for careful clinical examination in determining 
whether further investigations are warranted in dysphagia diagnostics. 
6.1 GLOBUS PATIENTS’ CHARACTERISTICS
In our prospective studies (I, II), the median age of the 30 globus patients was 45 (range 22-67) 
and 67% were female. In our retrospective study (III), women comprised 78% of the study 
population and the median age of all 76 globus patients was 49.5 (range 20-88). Consequently, 
the age and gender distribution was similar to what previous studies have reported (Moloy & 
Charter 1982, Batch 1988a). Although women may seek heathcare more oft en, globus probably 
aff ects women under 50 years of age in particular (Moloy & Charter 1982, Batch 1988a, Galmiche 
et al. 2006). In studies I, II and III, the CCI indicated that globus patients were in good health 
overall. Th is result is inline with the fi nding that globus is a common symptom in otherwise 
healthy subjects (Th ompson & Heaton 1982).
6.2 THE ESOPHAGEAL BACKGROUND OF GLOBUS
For decades, GERD has been considered one of the main causes for globus, although strong 
evidence is still lacking. Th e positive association between globus and GERD, however, has 
only been investigated with outdated and inaccurate methods in small samples (Malcomson 
1968, Koufman 1991). It has also been unclear whether non-acid GERD may cause globus. In 
addition, globus has been connected to esophageal motor disorders and elevated UES pressure, 
but diagnoses are based on fi ndings using conventional manometry (Watson & Sullivan 1974, 
Färkkilä et al. 1994). Currently, novel investigation methods, HRM and 24-h MII-pH are available 
for more precise diagnostics. In this study (I), we recruited 30 globus patients to investigate 
whether TNE, HRM, and 24-h MII-pH could clarify the esophageal background of globus. 
We found that globus patients without refl ux symptoms did not have acid GERD in 24-h 
MII-pH. Moreover, these patients’ videolaryngoscopies revealed no LPR, as scored with the RFS, 
an eight-item severity scale developed to evaluate patient’s laryngeal fi ndings that are suggestive 
of LPR (Belafsky et al. 2001). Th e RFS has been criticized because laryngeal fi ndings suggesting 
refl ux may be present in 70% of healthy subjects as well (Hicks et al. 2002). However, our patients’ 
fi ndings in videolaryngoscopy were inline with those in 24-h MII-pH. 
Discussion
41
It has been speculated that globus patients may have non-acid GERD, which would explain 
why they do not benefi t from PPIs. In our study, 24-h MII-pH also excluded non-acid GERD as 
a cause of globus patients’ symptoms. Nevertheless, globus patients without hearthburn oft en 
receive a PPI prescription, perhaps as a trial to diagnose silent refl ux. In study I, 60% of globus 
patients had received a PPI prescription before referral to our clinic. Moreover, in study III 
one-third of globus patients were prescribed a PPI in our clinic. High-dose PPIs are, however, 
no more eff ective than placebo in the treatment of globus (Noordzij et al. 2001, Vaezi et al. 
2006). Furthermore, PPIs may have long-term side eff ects, requiring justifi cation for use of this 
medication (Ali et al. 2009). One globus patient in study I had a pathologic amount of proximal 
refl ux and a prolonged total refl ux time in 24-h MII-pH, but she reported aft erward that she 
had recently been experiencing refl ux symptoms. Currently, it is recommended that if globus is 
directly related to refl ux, the diagnosis is GERD instead of globus (Galmiche et al. 2006). 
In 24-h MII-pH, supragastric belching was diagnosed in globus patients more oft en than in 
controls. Belching is a physiological event to release the intragastric air that one has swallowed. 
However, a supragastric belch is generated when a rapid suction of air into the esophagus is 
expelled before it reaches the stomach. Some studies suggest a relationship between supragastric 
belching and GERD (Hemmink et al. 2009a). Nevertheless, supragastric belching in globus 
patients is a novel fi nding. Diff erent mechanisms for how a supragastric belch is created have 
been described. A patient may contract pharyngeal muscles to draw air into the esophagus or 
breathe in through a closed glottis (Bredenoord 2010). Aerophagia, which indicates increased 
swallowing of air, was also diagnosed more oft en in globus patients than in controls. Speech 
therapy techniques have been demonstrated to alleviate symptoms in patients with supragastric 
belching (Hemmink et al. 2010). It is possible that some globus patients may contract their 
pharyngeal muscles inappropriately because of their lump sensation, which may lead to 
supragastric belching and aerophagia. In the future, increased use of 24-h MII-pH may clarify 
the connection between globus and supragastric belching or aerophagia. Because speech therapy 
may be helpful in supragastric belching, 24-h MII-pH may be considered for globus patients 
with prolonged and inconvenient symptoms.
HRM revealed an esophageal motor disorder in half of the globus patients diagnosed by 
the Chicago classifi cation (Bredenoord et al. 2012). However, motor disorders were mainly 
minor and were similar to those that can also be detected in healthy subjects (Kahrilas et al. 
2015). Two globus patients had a diagnosis of a major motor disorder: one with absent peristalsis 
and one with EGJ outfl ow obstruction, a subtype of achalasia. Patients with absent peristalsis 
may complain of dysphagia, odonyphagia, heartburn, and regurgitation. However, manometric 
fi ndings poorly correlate to a patient’s symptoms and a patient with absent peristalsis may be 
asymptomatic as well (Smout & Fox 2012). In achalasia, a patient usually has diffi  culties in 
swallowing both solids and liquids and complains of chest pain (Vaezi & Richter 1999). One 
study of 21 globus patients presented a few patients with achalasia, decreased peristalsis and 
segmental aperistaltics measured by conventional manometry (Färkkilä et al. 1994). In that 
sample, motor disorders were mainly nonspecifi c which, at that time, referred to disorders 
other than achalasia, spasm, nutcracker esophagus, or LES dysfunction. A study by Moser et al. 
(1991) revealed that 7 globus patients out of 30 had achalasia and the authors discussed whether 
the globus sensation might precede further dysphagia. Because our patients with major motor 
disorders lacked dysphagia, they did not receive any treatment. Esophageal motor disorder as an 
etiologic cause for globus is an interesting possible explanatory mechanism, but requires further 
research with larger, prospective settings with the use of HRM.  
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In HRM, the globus patients’ mean basal and residual UES pressures were within normal 
limits and the diff erences between globus patients and controls were statistically non-signifi cant. 
Choi et al. (2013) compared globus patients, GERD patients, and normal controls and found 
a non-statistically signifi cant diff erence in UES basal pressure. Moreover, a study of globus 
patients, dysphagia patients, and normal controls indicated that the mean UES basal pressure was 
normal in globus patients and controls (Peng et al. 2015). However, in their multivariate model, 
a measurable UES residual pressure independently predicted globus. Both of these studies were 
retrospective. Th e fi ndings in our prospective study support the assumption that elevated UES 
pressure does not cause globus.
In TNE, 10% of globus patients had endoscopic esophagitis defi ned by the LA Classifi cation 
system (Lundell et al. 1999). However, one study among a normal population without refl ux 
symptoms showed that esophagitis was diagnosed in 9.5%, using gastroscopy (Ronkainen et al. 
2006). One-third of the globus patients had a histological fi nding of esophagitis, which was more 
frequent than in control patients with refl ux, however, that diff erence did not reach statistical 
signifi cance. Th e controls’ regular use of PPIs likely diminished their histological fi ndings of 
esophagitis. However, diff erent pathologists analyzed our specimens, which may have caused 
variation due to their subjective opinions. In addition, the histological diagnosis depends on how 
representative the specimen is. 
TNE is considered a well-tolerated investigation method and our patients did not experience 
any complications. We also showed that taking a hypopharyngeal biopsy is possible during 
TNE. However, one-third of the patients refused HRM and 24-h MII-pH aft er TNE, which may 
indicate that the experience was unpleasant for some patients. On the other hand, the knowledge 
that there was not any lump causing the symptom may have reassured the patient enough and 
they found further investigations unnecessary. 
In our study (I), TNE was performed by both an otorhinolaryngologist and a 
gastroenterologist together and also included investigation of the stomach and the beginning 
of the duodenum, but the examination showed no benefi t in globus diagnostics. Moreover, the 
biopsies, including those from the hypopharynx, did not reveal any additional fi ndings, such 
as eosinophilic esophagitis in globus patients, in this sample. In study III, TNE was performed 
on only one patient and the fi ndings were normal. Six patients underwent EGD with fi ve 
normal fi ndings and one duodenal ulcer. Study III showed that endoscopy was not a common 
investigation method in our clinic and that there was no benefi t to its use. Although, endoscopy 
has not been found useful in globus diagnostics, surveys to clinicians reveal that many have 
preferred to examine globus patients with the method (Webb et al. 2000). 
6.3 OTHER ETIOLOGICAL FACTORS IN GLOBUS
Globus patients typically have an ENT examination within normal limits, causing a diagnostic 
and therapeutic problem. Also, in our studies, globus patients’ fi ndings in ENT examination 
were minor and rare. In study II, none of the globus patients had any pathological neck 
palpation fi ndings. In study III, one patient had a palpation fi nding of goiter. In study II, the 
ENT examination was normal in all cases except in one patient with a lingual tonsil hypertrophy. 
In study III, the clinicians considered lingual tonsil hypertrophy as a cause of globus in 4% of 
patients. However, causality of the fi ndings is hard to determine, although some studies suggest 
that severe hypertrophy of the tongue base may cause globus (Mamede et al. 2004). Furthermore, 
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other local anatomical causes, such as the epiglottis touching the base of the tongue or the 
posterior pharyngeal wall, were suspected in single cases in study III. Partial epiglottectomy with 
CO2 laser relieved symptoms in globus patients with the epiglottis touching the base of their 
tongue in a study by Agada et al. (2007). However, because controls were lacking, the procedure 
itself may have had a placebo eff ect. 
In study III, the retrospective analysis of medical records showed that clinicians had 
determined the possible cause for a patient’s globus in half of the cases. Th e most common cause 
was suspected to be dry mucous membranes in 17%. Th e side eff ects of a patient’s medication 
or drinking too little water may cause xerostomia and lead to thick mucus in the throat, causing 
a globus sensation. However, only one study has investigated the relationship between globus 
and epipharyngeal stagnant mucus (Shiomi et al. 2002). Aft er dry mucous membranes, muscle 
tension in the neck (16%) and voice disorders (7%) were the conditions second and the third most 
suspected for causing globus. In study II, the SLP interviewed and examined globus patients, and 
a functional voice problem was found in 26%. Other studies clarifying globus patients’ possible 
voice disorders are lacking. However, a controlled study by Khalil et al. (2003) showed that globus 
patients felt signifi cant improvement in their symptoms in the speech therapy group compared 
to the group receiving only reassurance. Also,  Wareing et al. (1997) suggested that laryngeal 
and pharyngeal tension may be partly associated with the globus symptom, fi nding in their non-
controlled study that 92% of globus patients felt improvement in their symptoms aft er speech 
therapy. However, it has been shown that when treating patients with non-organic dysphonia, 
speech therapy also has statistical benefi t in decreasing patients’ autonomic symptoms that are 
unrelated to voice (Demmink-Geertman & Dejonckere 2008). Th erefore, whether the globus 
patient benefi ts from a specifi c speech therapy or the attention itself remains ambiguous.
Historically, globus was considered solely a psychological problem. Although the 
understanding has changed, the psychological background is considered to be one etiologic 
cause. In study II, 10% of globus patients declared stress to be a factor in their lives. In study III, a 
concomitant psychological cause was evident in 8%. Th ose patients had simultaneously reported 
a stressful period of life with the occurrence of the globus. One case-control study observed that 
before the globus appeared, the patients had experienced a signifi cant event in their lives (Deary 
et al. 1992). Moreover, another study found that, throughout the year before the globus onset, 
globus patients confronted severe life events more oft en than controls (Harris et al. 1996). Th ese 
fi ndings are inline with ours in studies II and III. 
In study II, only a few patients had a diagnosis of depression (7%) or a bipolar disorder (3%). 
In study III, based on medical records, 14% had an SSRI medication and a psychiatric diagnosis, 
depression being the most prevalent (9%). Currently, about 6% of the Finnish population has the 
diagnosis of depression (Ferrari et al. 2013). Accordingly, in studies II and III, the distribution 
of depression is quite similar compared to the Finnish general population. A Finnish study 
by Färkkilä et al. (1994) concluded that psychiatric diagnoses among globus patients did not 
diff er from that of the general population. In contrast to their study, in both of our samples the 
psychiatric diagnoses were assessed before the patients were referred to the ENT clinic, while 
their study included a psychiatrist who evaluated the patients. In study II, the globus patients 
fi lled in the 15-D, which includes a question about depression. At baseline, globus patients 
were not more depressed than age-matched general population subjects, but at the four-month 
follow-up globus patients were more depressed. However, it is possible that in our small sample, 
a single patient’s outcome may have skewed the results. 
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6.4 RADIOLOGICAL EXAMINATIONS IN GLOBUS 
DIAGNOSTICS
Currently, studies concerning neck ultrasound and globus focus on thyroid pathology only. In 
study III, our review of the medical records revealed that neck ultrasound was performed on 
half of the globus patients. However, it was only useful in one patient who already had a palpable 
fi nding of an enlarged thyroid, which the ultrasound confi rmed to be a goiter. Other neck 
ultrasounds were within normal limits. An enlarged thyroid may cause compression symptoms 
and may also induce globus. In one prospective study, one third of patients with a thyroid mass 
complained of globus-like symptoms (Burns & Timon 2007). Our patient underwent thyroid 
lobectomy and became asymptomatic. Also, in the study by Burns & Timon (2007) 80% of 
patients felt that their globus was relieved aft er surgery. However, all surgical procedures may, 
themselves, have a curative eff ect and spontaneous recovery cannot be excluded completely. 
Some studies have suggested that thyroid nodules could also cause globus. One study 
showed that thyroid nodules larger than 3 cm, when locating anterior to the trachea, had an 
association with globus (Nam et al. 2015). In study III, one patient had a fi nding of a small, 
under 1 cm, thyroid nodule in neck ultrasound. She also had pain in palpation and therefore was 
referred for an MRI. Th e examination was unsuccessful, however, because she suff ered a panic 
attack. Aft er four years, she felt a palpable tumor in her neck, which was revealed to be thyroid 
cancer. As Nam et al. (2015) concluded, an association of small thyroid nodules with globus is 
improbable. Furthermore, our study showed that neck ultrasound did not provide any benefi t in 
globus diagnostics if there were no pathological palpation fi ndings in the neck. Consequently, 
neck ultrasound should be considered for globus patients only when palpable fi ndings exist.  
Videofl uorography was performed on almost one-third of globus patients in study III, 
but showed no benefi t in diagnostics. Our result is inline with other studies that have used 
radiographic swallow examinations in globus diagnostics (Luk et al. 2014, Dworkin et al. 2015). 
Videofl uorography is one of the gold standards in otorhinolaryngological practice for dysphagia 
diagnostics. However, globus patients without swallowing diffi  culties should not be examined 
with these procedures because they unneccassarily expose patients to a radiation load.  
Indeed, one reason to perform examinations, such as videofl uorography or neck ultrasound, 
is the need to convince the patient, and sometimes the clinician, that the globus is harmless. 
However, these examinations are not benefi cial in globus diagnostics and should be avoided. 
In addition, it is assumed that a patient will be satisfi ed if the clinician explains why further 
examinations are not necessary. 
6.5 GLOBUS ? PROGNOSIS AND THE FINNISH CANCER 
REGISTRY DATA 
In study II, we had the baseline and four-month follow-up questionnaires from 27 (90%) globus 
patients. During this four-month period, most patients underwent TNE, HRM, and 24-h MII-
pH, but they received no special treatment. Th e four-month follow-up ended, when globus 
patients met the SLP. During this visit, three patients disclosed that because they underwent the 
ENT examination and TNE with normal fi ndings they were convinced that their globus was 
harmless. 
Based on the baseline and follow-up questionnaires in study II, globus patients felt 
improvement in their symptoms, as measured by the RSI and DHI. Although these questionnaires 
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are not specifi cally targeted to globus patients, they are frequently used in our clinic, which is why 
they were chosen. In study II, globus patients’ symptoms had a median duration of six months at 
the initial visit. However, the exact duration of the symptoms was diffi  cult to estimate for many 
patients. A study by Timon et al. (1991) ascertained that globus symptoms experienced for only 
a short duration predicted faster recovery. Th is is inline with our fi nding in study II that most of 
the patients’ symptoms had lasted a quite short time at their initial visit and that symptoms also 
signifi cantly recovered during our short four-month follow-up. 
Th e RSI is used to evaluate possible laryngeal symptoms relating to LPR.  Belafsky et al. 
(2002) showed the usefulness of the RSI in a study where they used it before and aft er treatment 
and found that symptoms for LPR patients alleviated aft er PPI medication. In our study, 
GERD and LPR were excluded in globus patients with normal results from 24-h MII-pH and, 
furthermore, although they did not receive any treatment, they felt that their symptoms were 
relieved, as measured by the RSI. At the initial visit, over half of the patients had elevated scores 
suggesting LPR, but aft er the follow-up only 19% had elevated scores. Th erefore, the RSI was 
useful in evaluating the recovery of globus patients’ symptoms because the results were similar in 
the RSI and DHI. However, the RSI was not useful for diagnosing LPR. 
Th e DHI is a quality-of-life questionnaire directed for use in dysphagia patients (Woisard et 
al. 2006). Overall, globus patients had low scores in the DHI in studies II and III, as was suspected. 
We thought that the emotional subscale of the DHI would have been particularly useful for 
surveying globus patients’ symptoms and for better understanding how globus concerns them 
as well. During the follow-up of study II, total DHI scores, as well as the physical and emotional 
subscales, improved, but the functional subscale did not change, suggesting that those symptoms 
are experienced more permanently. 
In the 15-D, globus patients had worse scores in six dimensions compared with age-matched 
general population subjects at the initial visit. However, at the follow-up, globus patients did 
improve, though in only one subscale, but also felt more depressed. Consequently, the scores 
from the 15-D did not improve as the scores in the RSI and DHI did at follow-up. However, the 
RSI and DHI are concentrated on pharyngeal symptoms while the 15-D focuses on diff erent 
parts of a patient’s life. Accordingly, our study suggests that globus symptoms may alleviate quite 
fast, but whether the alleviation is caused by spontaneous recovery, fl uctuating symptoms or 
patients benefi ting from evidence that their symptoms are harmless remains unanswered.
In study III, globus patients initially examined in our clinic in 2009 received a questionnaire 
concerning their present symptoms three and six years later. At both follow-ups, approximately 
half of the patients reported that they were asymptomatic or that they had fewer symptoms 
than at the initial visit. However, almost half of the patients felt that their symptoms were the 
same at follow-ups. Whether the patient had a suspected cause for his or her globus did not 
infl uence these globus self-ratings. Our follow-up time was at least six years from the initial visit; 
consequently, our results regarding the persistence of globus are inline with other studies with 
average follow-ups of 27 months and 7.6 years (Timon et al. 1991, Rowley et al. 1995). 
In study III, the FCR data confi rmed that during the three-year follow-up none of the 76 
globus patients developed a malignancy in the upper aerodigestive tract or in the head and neck 
area, of which globus could have been an early symptom. In a study by Rowley et al. (1995) none 
of the 74 globus patients developed an upper aerodigestive track malignancy during the seven-
year follow-up. However, that study was based on a questionnaire, and if a patient noted they 
were symptomatic, re-examination was performed. In our study (III), the data were collected 
from the FCR, thus, no cases of cancer were missed. Moreover, in studies I and III, TNE and EGD 
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revealed no tumors, which is inline with other studies (Takwoingi et al. 2006). Consequently, a 
malignancy should not be suspected in a patient with typical globus.
6.6 DYSPHAGIA ? CAUSES AND OUTCOME
In study IV, we had 303 dysphagia patients who were referred to our clinic in 2009. Some patients’ 
symptoms were mild and occurred only occasionally. Consequently, the clinicians prescribed 
no further examinations to those patients and patients received only instructions. Over half of 
the patients underwent videofl uorography. A suspicion of structural abnormalities, for example 
Zenker’s diverticulum, is an indication for videofl uorography. Videofl uorography also enables 
evaluation of the swallowing process, cricopharyngeus muscle dysfunction and can reveal 
possible aspiration. However, Zenker’s diverticulum and cricopharyngeus muscle dysfunction 
were evident in only 9%. In most cases, the videofl uorography result was normal. Accordingly, 
many of the investigations could have been avoided by taking a more careful patient history. 
Spieker (2000) concluded that a careful patient history might reveal the cause of dysphagia in up 
to 85% of cases.
FEES was the second most oft en performed examination. It is both a diagnostic and 
therapeutic procedure and enables clinicians to properly instruct patients with a swallowing 
diffi  culty. FEES is recommended to be performed on patients with oropharyngeal dysphagia of 
a neurological origin if there is a need to evaluate the safety of swallowing; it also serves as a 
rehabilitation procedure. In our study, patients with neurogenic dysphagia had usually already 
had their neurological diagnosis and had come for consultation. However, a few patients, whose 
oropharyngeal dysphagia was later diagnosed as neurogenic, were referred to our clinic fi rst. 
Th e ENT examination, which included testing of the neurological background of swallowing, 
aroused the suspicion of a neurological cause and directed these patients to further consultation. 
Accordingly, an ENT examination should always include neurological testing when examining 
patients with oropharyngeal dysphagia (Figure 1). 
Neck ultrasound was performed in 12% of dysphagia patients. Th e reason for ultrasound 
was probably to diagnose a possible goiter causing a patient’s swallowing diffi  culty. However, 
based on medical records, only one patient had a goiter and it was already evident in neck 
palpation. She underwent thyroidectomy and felt her dysphagia was relieved. Patients with goiter 
who complain of swallowing diffi  culties preoperatively experience signifi cant improvement 
in their symptoms aft er thyroidectomy (Greenblatt et al. 2009). Although it is possible that an 
enlarged thyroid may cause compression and impair swallowing, such an enlargement seen in 
a neck ultrasound would most likely have been palpable as well. Consequently, compression 
symptoms concomitant with an enlarged thyroid are usually related to the size of the thyroid 
(Banks et al. 2012). However, retrosternal goiter, which may cause dysphagia, usually requires 
computed tomography, or MRI, for the diagnosis (Shaha 1990). 
EGD, TNE, manometry and pH measurement were performed only on a limited amount of 
patients in our clinic, since these are investigations used in esophageal dysphagia. A substantial 
amount of patients whose dysphagia symptoms aff ect the esophageal phase of swallowing are 
usually referred to gastroenterological units for EGD. However, based on the medical records, 
a suspicion of GERD (17%) was the most oft en identifi able cause for patients’ symptoms in our 
sample. GERD is known to be the most common cause for esophageal dysphagia (Watson & Lally 
2009). In our study, the diagnosis was usually based on patients’ alleviation of symptoms with 
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PPI. To diagnose possible GERD, empiric PPI therapy is permitted, but those whose symptoms 
do not resolve should be examined further with EGD (Katz et al. 2013).
Th ere were only a few dysphagia patients with malignancy, and in all cases the suspicion 
was already evident. Th e diagnoses were revealed in either the ENT examination or an EGD was 
performed because of the patient’s progressive dysphagia and food impaction in the esophagus. 
Alarming signs and fi ndings, such as weight loss, progressive dysphagia symptoms with food 
impaction in the throat or esophagus require immediate evaluation to exclude a malignancy. In 
our study, the FCR data confi rmed that if the patient lacked these alarming signs and the ENT 
examination was normal, the patient’s symptom did not develop into a malignancy during the 
three-year follow-up. Th is emphasizes the importance of taking a careful patient history along 
with the ENT examination.
Th e survey of medical records revealed that the cause of the dysphagia patient’s symptoms 
remained unclear in 55%. Some dysphagia symptoms may occur only occasionally, may be related 
to hasty eating habits or have a psychological background. Hoy et al. (2013) retrospectively 
investigated 100 dysphagia patients’ diagnoses at their tertiary-care voice and swallowing 
center and the cause of dysphagia remained unspecifi c in 20%. Th ey speculated that mucosal 
hypersensitivity and a psychological background, including malingering, were possible causes 
for those patients’ symptoms. 
Th e questionnaire concerning patients’ current symptoms at the three-year follow-up 
revealed that almost half of the dysphagia patients felt that their symptoms had alleviated or 
disappeared. As seen in the patients’ DHI scores, those with neurogenic dysphagia had the 
worst scores, indicating that neurogenic dysphagia is more oft en permanent and progressive. 
However, patients whose dysphagia remained unspecifi c indicated a low median score in the 
DHI, suggesting that their symptoms were mild and likely did not worsen remarkably during the 
follow-up. 
Dysphagia is a multifaceted symptom. With a careful patient history, a clinician must fi rst 
distinguish at what phase of swallowing the problem is located: oral, pharyngeal, or esophageal 
phase. Possible neurological symptoms and signs should be noted and patients with alarming 
signs suggesting a malignancy require immediate examination. Based on our study and 
experience, we created algorithms to guide how best to examine patients with oropharyngeal 
(Figure 4) and esophageal dysphagia (Figure 5). Evaluation of dysphagia patients in the right 
place, at the right time safeguards against both wasted resources and delays in investigating the 
patients’ symptoms.
6.7 LIMITATIONS OF THE STUDY
In study I, we were only able to recruit a limited number of patients due to the study’s resource-
demanding setting. Th e invasive investigations may be the reason that one-third of globus patients 
refused HRM and 24-h MII-pH aft er TNE, which reduced the available data. Th e relatively low 
number of globus patients and controls may cause false positive results (type I error), but based 
on our power calculation, this seems unlikely. In study II, we did not have a psychiatrist who 
could have evaluated the psychological state of patients, however, it is possible that some patients 
would have felt uncomfortable in that setting and may have refused. Furthermore, we did not use 
a depression questionnaire, but the 15-D did contain one question regarding depression. Th e fact 
that we had no normal controls with an SLP interview and examination is a limitation. Moreover, 
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patients’ voice evaluations could have been more precisely documented. Since studies III and 
IV were retrospective, some medical records were defi cient and lacked the clinician’s opinion of 
the reason causing the patient’s symptom. Additionally, since the FCR data are published with 
a delay, we only had data through the end of 2012. In studies III and IV, there may be a small 
chance of a false negative result (type II error) because the follow-up time was only three years 
and malignancy is supposed to be rare in these patient groups. In patient surveys, response rates 
are oft en low, indeed, in studies III and IV, we only received answers from 39-62% of patients, 
which may reduce the reliability of the study. 
6.8 FUTURE PERSPECTIVES
Currently, new investigation methods, such as HRM and 24-h MII-pH, enable more accurate 
diagnostics and further studies will clarify if our fi ndings of supragastric belching, aerophagia 
and major esophageal motor disorders are overrepresented in globus patients. Th is knowledge 
would also enhance the available treatment options since treatment has mainly been to give 
reassurance to the patients. Some globus patients seem to have a coexisting voice problem, which 
may increase the SLP’s role in globus diagnostics and treatment. 
Findings in ENT 
examinations 
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Figure 4 Algorithm for oropharyngeal dysphagia diagnostics. 
 ENT=ear, nose, and throat; VFG=videofl uorography; TNE= transnasal esophagoscopy; 
 EGD=esophagogastroduodenoscopy; ZD=Zenker’s diverticulum; UES=upper esophageal 
sphincter; FEES=fi beroptic endoscopic evaluation of swallowing. 
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In our study, dysphagia patients underwent many investigations with mainly normal fi ndings. 
Accordingly, many investigations were performed unnecessarily. Th e use of an algorithm would 
allow for diagnosing dysphagia patients in a more systematic way. Multidisciplinary cooperation 
in the diagnostics and treatment are also warranted in order to use resources sensibly and for the 
best care of the patient. It would be benefi cial to consider whether dysphagia clinics in tertiary 
care units could improve patient care in the future.
Figure 5 Algorithm for esophageal dysphagia diagnostics. 
 TNE=transnasal esophagoscopy; EGD=esophagogastroduodenoscopy; 
 HRM=high-resolution manometry; 24-h MII-pH=24-hour multichannel intraluminal 
impedance and pH monitoring
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7 CONCLUSIONS
1. Globus patients without refl ux symptoms did not have acid or non-acid 
gastroesophageal refl ux disease in 24-hour multichannel intraluminal impedance 
(MII) and pH monitoring. However, in MII, globus patients had supragastric belching 
more oft en than controls with refl ux symptoms, suggesting its role in some globus 
patients’ symptoms. Th e upper esophageal sphincter pressure was not elevated in 
globus patients in high-resolution manometry (HRM). If an esophageal motor disorder 
was diagnosed in HRM, it was usually a minor disorder, oft en also detected in healthy 
subjects. Moreover, transnasal esophagoscopy with biopsies, including examination 
of the stomach and the beginning of the duodenum, showed no benefi t in globus 
diagnostics. 
2. Globus patients showed signifi cant symptom relief at the four-month follow-up, as 
measured by the Deglutition Handicap Index and the Refl ux Symptom Index. Th e 
speech and language pathologist’s interview and examination revealed 6 (26%) globus 
patients with functional voice problems, possibly associated with persistent globus.
3. Neck ultrasound was not benefi cial in patients whose neck palpation was normal. 
Moreover, videofl uorography did not add any clinically relevant information in globus 
diagnostics. 
4. Aft er a three- and six-year follow-up, almost half of the globus patients experienced 
persistent symptoms, indicating that globus may cause long-term discomfort. Th e 
Finnish Cancer Registry (FCR) data verifi ed that none of the globus patients developed 
a malignancy over the three-year follow-up. Dysphagia patients without alarming signs 
or fi ndings in the ear, nose, and throat examination revealed no malignancies during 
a three-year follow-up, confi rmed by the FCR. Almost half of the dysphagia patients 
became asymptomatic or had fewer symptoms aft er three years, indicating the possible 
spontaneous recovery of the condition. 
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APPENDICES
APPENDIX 1. THE REFLUX FINDING SCORE ?RFS?1 
Pseudosulcus (infraglottic edema) 0=Absent, 2=Present 
Ventricular obliteration 2=Partial, 4=Complete 
Erythema and hyperemia 2=Arytenoids, 4=Diff use 
Vocal fold edema 1=Mild, 2=Moderate, 3=Severe, 4=Polypoid                      
Diff use laryngeal edema 1=Mild, 2=Moderate, 3=Severe, 4=Obstructing 
Posterior commissure hypertrophy 0=Absent, 2=Present 
Granuloma/granulation tissue 0=Absent, 2=Present 
Th ick endolaryngeal mucus 0=Absent, 2=Present 
1 A total score over six is considered suggestive of laryngopharyngeal refl ux.
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Appendices
APPENDIX 2. THE REFLUX SYMPTOM INDEX ?RSI?2
Within the last month, how much did 
the following problems aff ect you? 
Circle the appropriate response 
0=No Problem   5=Severe problem 
1. Hoarseness or a problem with your 
voice 0 1 2 3 4 5
2. Clearing your throat 0 1 2 3 4 5
3. Excess throat mucus or postnasal 
drip 0 1 2 3 4 5
4. Diffi  culty swallowing food, liquids, 
or pills 0 1 2 3 4 5
5. Coughing aft er you eat or aft er lying 
down 0 1 2 3 4 5
6. Breathing diffi  culties or choking 
episodes 0 1 2 3 4 5
7. Troublesome or annoying cough 0 1 2 3 4 5
8. Sensation of something sticking to 
your throat or a lump in your throat 0 1 2 3 4 5
9. Heartburn, chest pain, indigestion, or 
stomach acid coming up 0 1 2 3 4 5
  Total 
2 A total score over 13 is considered abnormal, suggesting laryngopharyngeal refl ux.
64
APPENDIX 3. THE DEGLUTITION HANDICAP INDEX ?DHI?3
Physical subscale N AN S AA A
I feel discomfort when I swallow 0 1 2 3 4
Food sticks or stays blocked in my throat 0 1 2 3 4
I have diffi  culty swallowing liquids 0 1 2 3 4
I cough or clear my throat during or aft er a meal 0 1 2 3 4
I suff ocate when eating or drinking 0 1 2 3 4
I feel food or liquid coming up aft er a meal 0 1 2 3 4
I have diffi  culty chewing 0 1 2 3 4
Food comes up to my nose when I eat or drink 0 1 2 3 4
I dribble when I eat 0 1 2 3 4
My throat hurts when I swallow 0 1 2 3 4
Functional subscale
I am unable to eat certain foods because of my swallowing 
diffi  culties 0 1 2 3 4
I have to modify the consistency of my food in order to 
swallow 0 1 2 3 4
It takes longer to eat a meal because of my swallowing 
diffi  culties 0 1 2 3 4
I eat less because of my swallowing problems 0 1 2 3 4
I am still hungry or thirsty aft er a meal 0 1 2 3 4
I am tired because of my swallowing problems 0 1 2 3 4
I have lost weight because of my swallowing diffi  culties 0 1 2 3 4
I am afraid of eating 0 1 2 3 4
I have had bronchitis or pulmonary infections more oft en 
since my swallowing problems 0 1 2 3 4
I have more trouble breathing since my swallowing 
problems 0 1 2 3 4
Emotional subscale
I avoid eating with others because of my swallowing 
diffi  culties 0 1 2 3 4
My swallowing problem limits my personal or social life 0 1 2 3 4
I am bothered by the way I eat during meals 0 1 2 3 4
Eating has become a disagreable time because of my 
swallowing problems 0 1 2 3 4
I fi nd that others do not understand my swallowing 
problems 0 1 2 3 4
Others seem to be irritated by my swallowing problems 0 1 2 3 4
I am tense when I eat with others because of my swallowing 
problems 0 1 2 3 4
I am ashamed of my swallowing problem 0 1 2 3 4
I feel handicapped because of my swallowing diffi  culties 0 1 2 3 4
Total
N=never, AN=almost never, S=sometimes, AA=almost always, A=always
3 A total score over 20 and/or 9 points or more in a subscale is considered abnormal. 
Appendices
65
APPENDIX 4. THE 15?DIMENSIONAL MEASURE OF HEALTH?
RELATED QUALITY OF LIFE ?15?D?
Please read through all of the alternative responses to each question before placing a cross (x) for 
the alternative which best describes your present health status. Continue through all 15 questions 
in this manner, giving only one answer to each. 
QUESTION 1. MOBILITY 
1 ( ) I am able to walk normally (without diffi  culty) indoors, outdoors and on stairs. 
2 ( ) I am able to walk without diffi  culty indoors, but outdoors and/or on stairs I have slight diffi  culties. 
3 ( ) I am able to walk without help indoors (with or without an appliance), but outdoors and/or on 
stairs only with considerable diffi  culty or with help from others. 
4 ( ) I am able to walk indoors only with help from others. 
5 ( ) I am completely bed-ridden and unable to move about. 
QUESTION 2. VISION 
1 ( ) I see normally, i.e. I can read newspapers and TV text without diffi  culty (with or without glasses). 
2 ( ) I can read papers and/or TV text with slight diffi  culty (with or without glasses). 
3 ( ) I can read papers and/or TV text with considerable diffi  culty (with or without glasses). 
4 ( ) I cannot read papers or TV text either with glasses or without, but I can see enough to walk about 
without guidance. 
5 ( ) I cannot see enough to walk about without a guide, i.e. I am almost or completely blind. 
QUESTION 3. HEARING 
1 ( ) I can hear normally, i.e. normal speech (with or without a hearing aid). 
2 ( ) I hear normal speech with a little diffi  culty. 
3 ( ) I hear normal speech with considerable diffi  culty; in conversation, I need voices to be louder than 
normal. 
4 ( ) I hear even loud voices poorly; I am almost deaf. 
5 ( ) I am completely deaf. 
QUESTION 4. BREATHING 
1 ( ) I am able to breathe normally, i.e. with no shortness of breath or other breathing diffi  culty. 
2 ( ) I have shortness of breath during heavy work or sports, or when walking briskly on fl at ground 
or slightly uphill. 
3 ( ) I have shortness of breath when walking on fl at ground at the same speed as others my age. 
4 ( ) I have shortness of breath even aft er light activity, e.g. washing or dressing myself. 
5 ( ) I have breathing diffi  culties almost all the time, even when resting. 
QUESTION 5. SLEEPING 
1 ( ) I am able to sleep normally, i.e. I have no problems with sleeping. 
2 ( ) I have slight problems with sleeping, e.g. diffi  culty in falling asleep, or sometimes waking at night. 
3 ( ) I have moderate problems with sleeping, e.g. disturbed sleep, or feeling I have not slept enough. 
4 ( ) I have great problems with sleeping, e.g. having to use sleeping pills oft en or routinely, or usually 
waking at night and/or too early in the morning. 
5 ( ) I suff er severe sleeplessness, e.g. sleep is almost impossible even with full use of sleeping pills, or 
staying awake most of the night. 
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QUESTION 6. EATING 
1 ( ) I am able to eat normally, i.e. with no help from others. 
2 ( ) I am able to eat by myself with minor diffi  culty (e.g. slowly, clumsily, shakily, or with special 
appliances). 
3 ( ) I need some help from another person to eat. 
4 ( ) I am unable to eat by myself at all, so I must be fed by another person. 
5 ( ) I am unable to eat at all, so I am fed either by tube or intravenously. 
QUESTION 7. SPEECH 
1 ( ) I am able to speak normally, i.e. clearly, audibly and fl uently. 
2 ( ) I have slight speech diffi  culties, e.g. occasional fumbling for words, mumbling, or changes of pitch. 
3 ( ) I can make myself understood, but my speech is, for example, disjointed, faltering, stuttering or 
stammering. 
4 ( ) Most people have great diffi  culty understanding my speech. 
5 ( ) I can only make myself understood by gestures. 
QUESTION 8. ELIMINATION 
1 ( ) My bladder and bowel work normally and without problems. 
2 ( ) I have slight problems with my bladder and/or bowel function, e.g. diffi  culties with urination, or 
loose or hard bowels. 
3 ( ) I have marked problems with my bladder and/or bowel function, e.g. occasional ‘accidents’, or 
severe constipation or diarrhea. 
4 ( ) I have serious problems with my bladder and/or bowel function, e.g. routine ‘accidents’, or need 
of catheterization or enemas. 
5 ( ) I have no control over my bladder and/or bowel function. 
QUESTION 9. USUAL ACTIVITIES 
1 ( ) I am able to perform my usual activities (e.g. employment, studying, housework, free-time 
activities) without diffi  culty. 
2 ( ) I am able to perform my usual activities slightly less eff ectively or with minor diffi  culty. 
3 ( ) I am able to perform my usual activities much less eff ectively, with considerable diffi  culty, or not 
completely. 
4 ( ) I can only manage a small proportion of my previous usual activities. 
5 ( ) I am unable to manage any of my previous usual activities. 
QUESTION 10. MENTAL FUNCTION 
1 ( ) I am able to think clearly and logically, and my memory functions well 
2 ( ) I have slight diffi  culties in thinking clearly and logically, or my memory sometimes fails me. 
3 ( ) I have marked diffi  culties in thinking clearly and logically, or my memory is somewhat impaired. 
4 ( ) I have great diffi  culties in thinking clearly and logically, or my memory is seriously impaired. 
5 ( ) I am permanently confused and disoriented in place and time. 
QUESTION 11. DISCOMFORT AND SYMPTOMS 
1 ( ) I have no physical discomfort or symptoms, e.g. pain, ache, nausea, itching, etc. 
2 ( ) I have mild physical discomfort or symptoms, e.g. pain, ache, nausea, itching, etc. 
3 ( ) I have marked physical discomfort or symptoms, e.g. pain, ache, nausea, itching, etc. 
4 ( ) I have severe physical discomfort or symptoms, e.g. pain, ache, nausea, itching, etc. 
5 ( ) I have unbearable physical discomfort or symptoms, e.g. pain, ache, nausea, itching, etc. 
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QUESTION 12. DEPRESSION 
1 ( ) I do not feel at all sad, melancholic or depressed. 
2 ( ) I feel slightly sad, melancholic or depressed. 
3 ( ) I feel moderately sad, melancholic or depressed. 
4 ( ) I feel very sad, melancholic or depressed. 
5 ( ) I feel extremely sad, melancholic or depressed. 
QUESTION 13. DISTRESS 
1 ( ) I do not feel at all anxious, stressed or nervous. 
2 ( ) I feel slightly anxious, stressed or nervous. 
3 ( ) I feel moderately anxious, stressed or nervous. 
4 ( ) I feel very anxious, stressed or nervous. 
5 ( ) I feel extremely anxious, stressed or nervous. 
QUESTION 14. VITALITY 
1 ( ) I feel healthy and energetic. 
2 ( ) I feel slightly weary, tired or feeble. 
3 ( ) I feel moderately weary, tired or feeble. 
4 ( ) I feel very weary, tired or feeble, almost exhausted. 
5 ( ) I feel extremely weary, tired or feeble, totally exhausted. 
QUESTION 15. SEXUAL ACTIVITY 
1 ( ) My state of health has no adverse eff ect on my sexual activity. 
2 ( ) My state of health has a slight eff ect on my sexual activity. 
3 ( ) My state of health has a considerable eff ect on my sexual activity. 
4 ( ) My state of health makes sexual activity almost impossible. 
5 ( ) My state of health makes sexual activity impossible.
15D©/Harri Sintonen 
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